id,indicator_code,spatial_dim_type,iso_code,time_dim_type,region_code,region,dim1type,dim1,year,dim2type,dim2,dim3type,dim3,data_source_dim_type,data_source_dim,value,numeric_value,low,high,comments,date,time_dimension_value,time_dimension_begin,time_dimension_end,country,indicator_name,language,title
2712,SCSUD_PHARM,COUNTRY,TJK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tajikistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7176,SCSUD_PHARM,COUNTRY,PRY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Paraguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
22089,SCSUD_PHARM,COUNTRY,IRN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iran (Islamic Republic of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
29423,SCSUD_PHARM,COUNTRY,DEU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Germany,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
35761,SCSUD_PHARM,COUNTRY,DEU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Germany,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
39653,SCSUD_PHARM,COUNTRY,ESP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Spain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
40408,SCSUD_PHARM,COUNTRY,IND,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,India,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
47483,SCSUD_PHARM,COUNTRY,ITA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Italy,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
59057,SCSUD_PHARM,COUNTRY,AZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Azerbaijan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
110404,SCSUD_PHARM,COUNTRY,ITA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Italy,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
115882,SCSUD_PHARM,COUNTRY,ESP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Spain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
117084,SCSUD_PHARM,COUNTRY,CZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Czechia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
117435,SCSUD_PHARM,COUNTRY,KAZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kazakhstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
121747,SCSUD_PHARM,COUNTRY,TUR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,TÃ¼rkiye,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
166144,SCSUD_PHARM,COUNTRY,GEO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Georgia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
168498,SCSUD_PHARM,COUNTRY,BGD,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bangladesh,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
173138,SCSUD_PHARM,COUNTRY,LCA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Lucia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
178531,SCSUD_PHARM,COUNTRY,KOR,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Korea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
178991,SCSUD_PHARM,COUNTRY,CPV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cabo Verde,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
187026,SCSUD_PHARM,COUNTRY,BRB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Barbados,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
200615,SCSUD_PHARM,COUNTRY,KAZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kazakhstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
237416,SCSUD_PHARM,COUNTRY,MKD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,North Macedonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
241986,SCSUD_PHARM,COUNTRY,BWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Botswana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
244454,SCSUD_PHARM,COUNTRY,SYC,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Seychelles,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
248072,SCSUD_PHARM,COUNTRY,LUX,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Luxembourg,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
261037,SCSUD_PHARM,COUNTRY,KNA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Kitts and Nevis,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
263571,SCSUD_PHARM,COUNTRY,GRD,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Grenada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
269648,SCSUD_PHARM,COUNTRY,SMR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,San Marino,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
294497,SCSUD_PHARM,COUNTRY,KGZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kyrgyzstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
312027,SCSUD_PHARM,COUNTRY,BLR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belarus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
336377,SCSUD_PHARM,COUNTRY,GHA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ghana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
344598,SCSUD_PHARM,COUNTRY,PNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Papua New Guinea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
348025,SCSUD_PHARM,COUNTRY,TZA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Republic of Tanzania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
349610,SCSUD_PHARM,COUNTRY,MMR,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Myanmar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
356820,SCSUD_PHARM,COUNTRY,AND,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Andorra,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
381857,SCSUD_PHARM,COUNTRY,ZWE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zimbabwe,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
392777,SCSUD_PHARM,COUNTRY,HND,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Honduras,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
404929,SCSUD_PHARM,COUNTRY,MKD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,North Macedonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
406919,SCSUD_PHARM,COUNTRY,BDI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burundi,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
417784,SCSUD_PHARM,COUNTRY,PER,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Peru,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
437643,SCSUD_PHARM,COUNTRY,IND,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,India,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
443004,SCSUD_PHARM,COUNTRY,GRC,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Greece,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
443094,SCSUD_PHARM,COUNTRY,SEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Senegal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
470253,SCSUD_PHARM,COUNTRY,TON,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tonga,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
483894,SCSUD_PHARM,COUNTRY,MCO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Monaco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
490300,SCSUD_PHARM,COUNTRY,BTN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bhutan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
515499,SCSUD_PHARM,COUNTRY,GRD,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Grenada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
515925,SCSUD_PHARM,COUNTRY,SGP,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Singapore,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
521704,SCSUD_PHARM,COUNTRY,NIC,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nicaragua,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
521918,SCSUD_PHARM,COUNTRY,COD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Democratic Republic of the Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
526077,SCSUD_PHARM,COUNTRY,AFG,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Afghanistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
533128,SCSUD_PHARM,COUNTRY,LVA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Latvia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
540073,SCSUD_PHARM,COUNTRY,JOR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jordan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
570391,SCSUD_PHARM,COUNTRY,MNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mongolia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
572788,SCSUD_PHARM,COUNTRY,AUS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Australia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
598278,SCSUD_PHARM,COUNTRY,CZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Czechia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
608269,SCSUD_PHARM,COUNTRY,SWZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Eswatini,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
609102,SCSUD_PHARM,COUNTRY,KAZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kazakhstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
635264,SCSUD_PHARM,COUNTRY,HRV,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Croatia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
639938,SCSUD_PHARM,COUNTRY,BEL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belgium,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
640456,SCSUD_PHARM,COUNTRY,LKA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sri Lanka,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
647349,SCSUD_PHARM,COUNTRY,PNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Papua New Guinea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
673214,SCSUD_PHARM,COUNTRY,ZAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Africa,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
684673,SCSUD_PHARM,COUNTRY,LKA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sri Lanka,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
686807,SCSUD_PHARM,COUNTRY,PER,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Peru,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
710273,SCSUD_PHARM,COUNTRY,JOR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jordan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
711767,SCSUD_PHARM,COUNTRY,POL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Poland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
712170,SCSUD_PHARM,COUNTRY,ATG,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Antigua and Barbuda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
728828,SCSUD_PHARM,COUNTRY,NPL,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nepal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
747751,SCSUD_PHARM,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bahrain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
750022,SCSUD_PHARM,COUNTRY,BLZ,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belize,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
762226,SCSUD_PHARM,COUNTRY,BRB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Barbados,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
779621,SCSUD_PHARM,COUNTRY,URY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uruguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
779689,SCSUD_PHARM,COUNTRY,ATG,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Antigua and Barbuda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
779983,SCSUD_PHARM,COUNTRY,BTN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bhutan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
781453,SCSUD_PHARM,COUNTRY,ATG,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Antigua and Barbuda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
794443,SCSUD_PHARM,COUNTRY,ETH,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ethiopia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
804765,SCSUD_PHARM,COUNTRY,CHN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,China,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
806595,SCSUD_PHARM,COUNTRY,ECU,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ecuador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
825667,SCSUD_PHARM,COUNTRY,CRI,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Costa Rica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
832110,SCSUD_PHARM,COUNTRY,LTU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Lithuania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
844813,SCSUD_PHARM,COUNTRY,CHN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,China,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
875049,SCSUD_PHARM,COUNTRY,EGY,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Egypt,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
881732,SCSUD_PHARM,COUNTRY,SGP,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Singapore,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
894333,SCSUD_PHARM,COUNTRY,GRC,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Greece,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
894397,SCSUD_PHARM,COUNTRY,TKM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Turkmenistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
912782,SCSUD_PHARM,COUNTRY,MLI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mali,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
912789,SCSUD_PHARM,COUNTRY,PHL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Philippines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
928231,SCSUD_PHARM,COUNTRY,VCT,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
932141,SCSUD_PHARM,COUNTRY,ARM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Armenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
933792,SCSUD_PHARM,COUNTRY,AGO,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Angola,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
934207,SCSUD_PHARM,COUNTRY,SRB,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Serbia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
966011,SCSUD_PHARM,COUNTRY,GEO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Georgia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
970724,SCSUD_PHARM,COUNTRY,BWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Botswana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1004492,SCSUD_PHARM,COUNTRY,SUR,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Suriname,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1016951,SCSUD_PHARM,COUNTRY,BFA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burkina Faso,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1017841,SCSUD_PHARM,COUNTRY,MOZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mozambique,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1029789,SCSUD_PHARM,COUNTRY,BEL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belgium,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1056435,SCSUD_PHARM,COUNTRY,COL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Colombia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1061092,SCSUD_PHARM,COUNTRY,TJK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tajikistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1063497,SCSUD_PHARM,COUNTRY,BFA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burkina Faso,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1080520,SCSUD_PHARM,COUNTRY,SDN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1095902,SCSUD_PHARM,COUNTRY,CRI,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Costa Rica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1099856,SCSUD_PHARM,COUNTRY,NGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nigeria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1100362,SCSUD_PHARM,COUNTRY,MLI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mali,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1108095,SCSUD_PHARM,COUNTRY,BEL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belgium,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1114204,SCSUD_PHARM,COUNTRY,NLD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Netherlands (Kingdom of the),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1142997,SCSUD_PHARM,COUNTRY,GRD,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Grenada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1150761,SCSUD_PHARM,COUNTRY,PNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Papua New Guinea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1152408,SCSUD_PHARM,COUNTRY,PRY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Paraguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1158157,SCSUD_PHARM,COUNTRY,SDN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1162887,SCSUD_PHARM,COUNTRY,CAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Central African Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1164224,SCSUD_PHARM,COUNTRY,SWZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Eswatini,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1169132,SCSUD_PHARM,COUNTRY,BTN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bhutan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1182851,SCSUD_PHARM,COUNTRY,NOR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Norway,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1188375,SCSUD_PHARM,COUNTRY,ZMB,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zambia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1206842,SCSUD_PHARM,COUNTRY,AND,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Andorra,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1207515,SCSUD_PHARM,COUNTRY,BOL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bolivia (Plurinational State of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1219903,SCSUD_PHARM,COUNTRY,UKR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ukraine,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1220705,SCSUD_PHARM,COUNTRY,COG,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1238511,SCSUD_PHARM,COUNTRY,NLD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Netherlands (Kingdom of the),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1267034,SCSUD_PHARM,COUNTRY,HRV,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Croatia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1277390,SCSUD_PHARM,COUNTRY,DMA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1296150,SCSUD_PHARM,COUNTRY,BFA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burkina Faso,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1322554,SCSUD_PHARM,COUNTRY,MDA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Moldova,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1384790,SCSUD_PHARM,COUNTRY,IND,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,India,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1398991,SCSUD_PHARM,COUNTRY,CRI,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Costa Rica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1418953,SCSUD_PHARM,COUNTRY,BOL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bolivia (Plurinational State of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1423297,SCSUD_PHARM,COUNTRY,MLT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malta,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1438057,SCSUD_PHARM,COUNTRY,JOR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jordan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1441557,SCSUD_PHARM,COUNTRY,JAM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jamaica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1448928,SCSUD_PHARM,COUNTRY,UGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uganda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1455979,SCSUD_PHARM,COUNTRY,KEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kenya,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1466908,SCSUD_PHARM,COUNTRY,SDN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1479357,SCSUD_PHARM,COUNTRY,BEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Benin,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1492014,SCSUD_PHARM,COUNTRY,NPL,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nepal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1500220,SCSUD_PHARM,COUNTRY,NGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nigeria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1504989,SCSUD_PHARM,COUNTRY,BGD,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bangladesh,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1511234,SCSUD_PHARM,COUNTRY,COD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Democratic Republic of the Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1519882,SCSUD_PHARM,COUNTRY,VCT,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1550462,SCSUD_PHARM,COUNTRY,URY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uruguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1558035,SCSUD_PHARM,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saudi Arabia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1580089,SCSUD_PHARM,COUNTRY,TCD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chad,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1587998,SCSUD_PHARM,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Pakistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1593527,SCSUD_PHARM,COUNTRY,ZMB,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zambia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1601606,SCSUD_PHARM,COUNTRY,HUN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Hungary,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1620251,SCSUD_PHARM,COUNTRY,PAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Panama,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1650211,SCSUD_PHARM,COUNTRY,RUS,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Russian Federation,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1664320,SCSUD_PHARM,COUNTRY,SOM,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Somalia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1670854,SCSUD_PHARM,COUNTRY,PHL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Philippines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1671884,SCSUD_PHARM,COUNTRY,IRN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iran (Islamic Republic of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1696024,SCSUD_PHARM,COUNTRY,BLR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belarus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1700881,SCSUD_PHARM,COUNTRY,ISL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iceland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1706793,SCSUD_PHARM,COUNTRY,HUN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Hungary,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1708700,SCSUD_PHARM,COUNTRY,ROU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Romania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1714959,SCSUD_PHARM,COUNTRY,MYS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malaysia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1720326,SCSUD_PHARM,COUNTRY,VUT,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Vanuatu,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1739008,SCSUD_PHARM,COUNTRY,AGO,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Angola,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1739101,SCSUD_PHARM,COUNTRY,MYS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malaysia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1740604,SCSUD_PHARM,COUNTRY,AUT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Austria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1766257,SCSUD_PHARM,COUNTRY,SYC,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Seychelles,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1827395,SCSUD_PHARM,COUNTRY,BLZ,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belize,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1834738,SCSUD_PHARM,COUNTRY,BGD,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bangladesh,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1853614,SCSUD_PHARM,COUNTRY,CHN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,China,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1871427,SCSUD_PHARM,COUNTRY,DOM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominican Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1884277,SCSUD_PHARM,COUNTRY,MNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mongolia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1886531,SCSUD_PHARM,COUNTRY,ATG,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Antigua and Barbuda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1890799,SCSUD_PHARM,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saudi Arabia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1922418,SCSUD_PHARM,COUNTRY,TON,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tonga,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1928515,SCSUD_PHARM,COUNTRY,ISL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iceland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1936857,SCSUD_PHARM,COUNTRY,SRB,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Serbia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1944231,SCSUD_PHARM,COUNTRY,SWZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Eswatini,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1954691,SCSUD_PHARM,COUNTRY,LCA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Lucia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1974972,SCSUD_PHARM,COUNTRY,BGD,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bangladesh,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1979506,SCSUD_PHARM,COUNTRY,CAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Central African Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1995130,SCSUD_PHARM,COUNTRY,AUS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Australia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2006187,SCSUD_PHARM,COUNTRY,MYS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malaysia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2014049,SCSUD_PHARM,COUNTRY,TCD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chad,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2051242,SCSUD_PHARM,COUNTRY,FIN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Finland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2054966,SCSUD_PHARM,COUNTRY,CHN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,China,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2076818,SCSUD_PHARM,COUNTRY,BLZ,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belize,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2099991,SCSUD_PHARM,COUNTRY,ETH,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ethiopia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2106192,SCSUD_PHARM,COUNTRY,MAR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Morocco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2108429,SCSUD_PHARM,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Oman,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2133351,SCSUD_PHARM,COUNTRY,LTU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Lithuania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2143922,SCSUD_PHARM,COUNTRY,SSD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2145675,SCSUD_PHARM,COUNTRY,MYS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malaysia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2151592,SCSUD_PHARM,COUNTRY,PER,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Peru,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2152588,SCSUD_PHARM,COUNTRY,BLR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belarus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2195031,SCSUD_PHARM,COUNTRY,PAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Panama,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2196729,SCSUD_PHARM,COUNTRY,GTM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guatemala,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2207243,SCSUD_PHARM,COUNTRY,MMR,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Myanmar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2208286,SCSUD_PHARM,COUNTRY,HND,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Honduras,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2221977,SCSUD_PHARM,COUNTRY,PRT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Portugal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2232241,SCSUD_PHARM,COUNTRY,NOR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Norway,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2238322,SCSUD_PHARM,COUNTRY,CYP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cyprus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2245100,SCSUD_PHARM,COUNTRY,DMA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2246853,SCSUD_PHARM,COUNTRY,LKA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sri Lanka,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2285243,SCSUD_PHARM,COUNTRY,GTM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guatemala,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2288871,SCSUD_PHARM,COUNTRY,NPL,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nepal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2291149,SCSUD_PHARM,COUNTRY,HND,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Honduras,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2291704,SCSUD_PHARM,COUNTRY,CZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Czechia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2298191,SCSUD_PHARM,COUNTRY,NLD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Netherlands (Kingdom of the),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2315862,SCSUD_PHARM,COUNTRY,LCA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Lucia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2315918,SCSUD_PHARM,COUNTRY,ARM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Armenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2327057,SCSUD_PHARM,COUNTRY,HRV,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Croatia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2328028,SCSUD_PHARM,COUNTRY,SVK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovakia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2335599,SCSUD_PHARM,COUNTRY,KOR,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Korea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2355665,SCSUD_PHARM,COUNTRY,BRB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Barbados,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2367224,SCSUD_PHARM,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tunisia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2371740,SCSUD_PHARM,COUNTRY,ROU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Romania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2372693,SCSUD_PHARM,COUNTRY,CRI,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Costa Rica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2391027,SCSUD_PHARM,COUNTRY,PNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Papua New Guinea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2422697,SCSUD_PHARM,COUNTRY,AUT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Austria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2430262,SCSUD_PHARM,COUNTRY,PRT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Portugal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2442428,SCSUD_PHARM,COUNTRY,FSM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Micronesia (Federated States of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2455513,SCSUD_PHARM,COUNTRY,JAM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jamaica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2462706,SCSUD_PHARM,COUNTRY,ZAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Africa,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2511516,SCSUD_PHARM,COUNTRY,SSD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2513200,SCSUD_PHARM,COUNTRY,SLV,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,El Salvador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2538417,SCSUD_PHARM,COUNTRY,LCA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Lucia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2542770,SCSUD_PHARM,COUNTRY,NIC,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nicaragua,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2550512,SCSUD_PHARM,COUNTRY,IDN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Indonesia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2562682,SCSUD_PHARM,COUNTRY,SVN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2563214,SCSUD_PHARM,COUNTRY,AUS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Australia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2621091,SCSUD_PHARM,COUNTRY,ISL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iceland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2638089,SCSUD_PHARM,COUNTRY,JOR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jordan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2643583,SCSUD_PHARM,COUNTRY,PNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Papua New Guinea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2670360,SCSUD_PHARM,COUNTRY,MEX,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mexico,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2671507,SCSUD_PHARM,COUNTRY,COL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Colombia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2720111,SCSUD_PHARM,COUNTRY,FIN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Finland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2722838,SCSUD_PHARM,COUNTRY,SWE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sweden,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2728542,SCSUD_PHARM,COUNTRY,KGZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kyrgyzstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2747232,SCSUD_PHARM,COUNTRY,COL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Colombia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2773645,SCSUD_PHARM,COUNTRY,TCD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chad,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2785726,SCSUD_PHARM,COUNTRY,FSM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Micronesia (Federated States of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2790817,SCSUD_PHARM,COUNTRY,PRT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Portugal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2798259,SCSUD_PHARM,COUNTRY,ZMB,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zambia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2804902,SCSUD_PHARM,COUNTRY,URY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uruguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2816841,SCSUD_PHARM,COUNTRY,KGZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kyrgyzstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2824619,SCSUD_PHARM,COUNTRY,DEU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Germany,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2824704,SCSUD_PHARM,COUNTRY,EST,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Estonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2839865,SCSUD_PHARM,COUNTRY,GTM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guatemala,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2852981,SCSUD_PHARM,COUNTRY,BOL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bolivia (Plurinational State of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2886013,SCSUD_PHARM,COUNTRY,SSD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2899410,SCSUD_PHARM,COUNTRY,SYC,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Seychelles,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2910788,SCSUD_PHARM,COUNTRY,GBR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2918679,SCSUD_PHARM,COUNTRY,GEO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Georgia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2953989,SCSUD_PHARM,COUNTRY,CUB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cuba,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2955663,SCSUD_PHARM,COUNTRY,FSM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Micronesia (Federated States of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2966678,SCSUD_PHARM,COUNTRY,SLE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sierra Leone,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3005971,SCSUD_PHARM,COUNTRY,AUT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Austria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3023350,SCSUD_PHARM,COUNTRY,IRN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iran (Islamic Republic of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3038320,SCSUD_PHARM,COUNTRY,ROU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Romania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3049271,SCSUD_PHARM,COUNTRY,CHE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Switzerland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3064475,SCSUD_PHARM,COUNTRY,AGO,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Angola,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3067522,SCSUD_PHARM,COUNTRY,SGP,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Singapore,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3067746,SCSUD_PHARM,COUNTRY,BEL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belgium,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3070579,SCSUD_PHARM,COUNTRY,SWZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Eswatini,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3083131,SCSUD_PHARM,COUNTRY,TCD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chad,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3101809,SCSUD_PHARM,COUNTRY,BTN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bhutan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3106761,SCSUD_PHARM,COUNTRY,TCD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chad,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3108075,SCSUD_PHARM,COUNTRY,IRQ,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iraq,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3108109,SCSUD_PHARM,COUNTRY,CHL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chile,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3119453,SCSUD_PHARM,COUNTRY,IRL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3121348,SCSUD_PHARM,COUNTRY,MLI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mali,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3124789,SCSUD_PHARM,COUNTRY,THA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Thailand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3132069,SCSUD_PHARM,COUNTRY,KNA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Kitts and Nevis,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3163337,SCSUD_PHARM,COUNTRY,COK,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cook Islands,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3170542,SCSUD_PHARM,COUNTRY,PAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Panama,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3183067,SCSUD_PHARM,COUNTRY,SYC,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Seychelles,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3189015,SCSUD_PHARM,COUNTRY,ATG,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Antigua and Barbuda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3207625,SCSUD_PHARM,COUNTRY,SDN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3241411,SCSUD_PHARM,COUNTRY,DMA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3261261,SCSUD_PHARM,COUNTRY,LKA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sri Lanka,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3272930,SCSUD_PHARM,COUNTRY,IDN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Indonesia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3277365,SCSUD_PHARM,COUNTRY,NLD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Netherlands (Kingdom of the),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3298359,SCSUD_PHARM,COUNTRY,KEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kenya,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3310538,SCSUD_PHARM,COUNTRY,BFA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burkina Faso,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3316077,SCSUD_PHARM,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Oman,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3324885,SCSUD_PHARM,COUNTRY,PNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Papua New Guinea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3330119,SCSUD_PHARM,COUNTRY,AGO,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Angola,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3330590,SCSUD_PHARM,COUNTRY,SWE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sweden,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3354195,SCSUD_PHARM,COUNTRY,URY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uruguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3375385,SCSUD_PHARM,COUNTRY,ARM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Armenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3380614,SCSUD_PHARM,COUNTRY,GRC,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Greece,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3381096,SCSUD_PHARM,COUNTRY,SYR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Syrian Arab Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3416929,SCSUD_PHARM,COUNTRY,GBR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3419423,SCSUD_PHARM,COUNTRY,PAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Panama,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3419994,SCSUD_PHARM,COUNTRY,PER,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Peru,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3425117,SCSUD_PHARM,COUNTRY,MOZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mozambique,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3425411,SCSUD_PHARM,COUNTRY,COD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Democratic Republic of the Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3436487,SCSUD_PHARM,COUNTRY,TKM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Turkmenistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3444015,SCSUD_PHARM,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saudi Arabia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3464170,SCSUD_PHARM,COUNTRY,SDN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3467484,SCSUD_PHARM,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saudi Arabia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3476507,SCSUD_PHARM,COUNTRY,CAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Central African Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3500346,SCSUD_PHARM,COUNTRY,BLZ,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belize,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3506813,SCSUD_PHARM,COUNTRY,FIN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Finland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3513556,SCSUD_PHARM,COUNTRY,GHA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ghana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3525031,SCSUD_PHARM,COUNTRY,GUY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guyana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3552469,SCSUD_PHARM,COUNTRY,NZL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,New Zealand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3587909,SCSUD_PHARM,COUNTRY,THA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Thailand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3589661,SCSUD_PHARM,COUNTRY,NGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nigeria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3608746,SCSUD_PHARM,COUNTRY,CAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Canada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3609449,SCSUD_PHARM,COUNTRY,RUS,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Russian Federation,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3614661,SCSUD_PHARM,COUNTRY,SMR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,San Marino,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3632533,SCSUD_PHARM,COUNTRY,FIN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Finland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3650699,SCSUD_PHARM,COUNTRY,KNA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Kitts and Nevis,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3653143,SCSUD_PHARM,COUNTRY,NGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nigeria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3653740,SCSUD_PHARM,COUNTRY,TKM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Turkmenistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3671146,SCSUD_PHARM,COUNTRY,RWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Rwanda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3676143,SCSUD_PHARM,COUNTRY,MKD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,North Macedonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3682494,SCSUD_PHARM,COUNTRY,BOL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bolivia (Plurinational State of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3683918,SCSUD_PHARM,COUNTRY,SVN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3694868,SCSUD_PHARM,COUNTRY,AND,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Andorra,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3695668,SCSUD_PHARM,COUNTRY,CHE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Switzerland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3702943,SCSUD_PHARM,COUNTRY,SUR,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Suriname,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3709129,SCSUD_PHARM,COUNTRY,GHA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ghana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3720963,SCSUD_PHARM,COUNTRY,PHL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Philippines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3728296,SCSUD_PHARM,COUNTRY,DNK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Denmark,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3745834,SCSUD_PHARM,COUNTRY,COG,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3764775,SCSUD_PHARM,COUNTRY,COG,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3771081,SCSUD_PHARM,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Pakistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3784679,SCSUD_PHARM,COUNTRY,ZWE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zimbabwe,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3786086,SCSUD_PHARM,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Oman,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3802499,SCSUD_PHARM,COUNTRY,KGZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kyrgyzstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3805206,SCSUD_PHARM,COUNTRY,VNM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Viet Nam,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3815070,SCSUD_PHARM,COUNTRY,MOZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mozambique,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3816408,SCSUD_PHARM,COUNTRY,BLR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belarus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3845363,SCSUD_PHARM,COUNTRY,MDA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Moldova,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3883672,SCSUD_PHARM,COUNTRY,MEX,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mexico,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3885304,SCSUD_PHARM,COUNTRY,FRA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,France,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3922184,SCSUD_PHARM,COUNTRY,GEO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Georgia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3927967,SCSUD_PHARM,COUNTRY,IDN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Indonesia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3928331,SCSUD_PHARM,COUNTRY,TCD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chad,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3930096,SCSUD_PHARM,COUNTRY,MKD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,North Macedonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3930225,SCSUD_PHARM,COUNTRY,CRI,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Costa Rica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3934119,SCSUD_PHARM,COUNTRY,LCA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Lucia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3935763,SCSUD_PHARM,COUNTRY,COL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Colombia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3940437,SCSUD_PHARM,COUNTRY,CHL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chile,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3941602,SCSUD_PHARM,COUNTRY,BDI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burundi,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3946720,SCSUD_PHARM,COUNTRY,FIN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Finland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3982526,SCSUD_PHARM,COUNTRY,PAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Panama,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3989468,SCSUD_PHARM,COUNTRY,VUT,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Vanuatu,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3989659,SCSUD_PHARM,COUNTRY,FRA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,France,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3996897,SCSUD_PHARM,COUNTRY,ISR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Israel,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4002756,SCSUD_PHARM,COUNTRY,CHE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Switzerland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4006774,SCSUD_PHARM,COUNTRY,PER,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Peru,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4009426,SCSUD_PHARM,COUNTRY,AFG,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Afghanistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4013256,SCSUD_PHARM,COUNTRY,SVK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovakia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4013991,SCSUD_PHARM,COUNTRY,COG,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4020344,SCSUD_PHARM,COUNTRY,ITA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Italy,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4026355,SCSUD_PHARM,COUNTRY,COG,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4034776,SCSUD_PHARM,COUNTRY,GTM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guatemala,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4034786,SCSUD_PHARM,COUNTRY,LUX,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Luxembourg,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4040931,SCSUD_PHARM,COUNTRY,BFA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burkina Faso,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4072912,SCSUD_PHARM,COUNTRY,BLZ,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belize,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4092298,SCSUD_PHARM,COUNTRY,CHL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chile,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4101671,SCSUD_PHARM,COUNTRY,MLI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mali,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4110244,SCSUD_PHARM,COUNTRY,BEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Benin,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4115853,SCSUD_PHARM,COUNTRY,UGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uganda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4129231,SCSUD_PHARM,COUNTRY,IND,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,India,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4134941,SCSUD_PHARM,COUNTRY,AUT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Austria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4159735,SCSUD_PHARM,COUNTRY,SMR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,San Marino,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4160765,SCSUD_PHARM,COUNTRY,IRQ,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iraq,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4190682,SCSUD_PHARM,COUNTRY,RWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Rwanda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4193105,SCSUD_PHARM,COUNTRY,CHL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chile,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4193549,SCSUD_PHARM,COUNTRY,EST,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Estonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4193651,SCSUD_PHARM,COUNTRY,LUX,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Luxembourg,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4199100,SCSUD_PHARM,COUNTRY,CHL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chile,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4210823,SCSUD_PHARM,COUNTRY,FRA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,France,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4260361,SCSUD_PHARM,COUNTRY,COD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Democratic Republic of the Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4273623,SCSUD_PHARM,COUNTRY,SVK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovakia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4281784,SCSUD_PHARM,COUNTRY,JOR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jordan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4286077,SCSUD_PHARM,COUNTRY,IRL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4293306,SCSUD_PHARM,COUNTRY,SYR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Syrian Arab Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4319062,SCSUD_PHARM,COUNTRY,IRQ,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iraq,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4326169,SCSUD_PHARM,COUNTRY,COL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Colombia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4338386,SCSUD_PHARM,COUNTRY,BGD,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bangladesh,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4350698,SCSUD_PHARM,COUNTRY,CIV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cote d'Ivoire,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4382967,SCSUD_PHARM,COUNTRY,AFG,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Afghanistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4414260,SCSUD_PHARM,COUNTRY,KHM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cambodia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4419520,SCSUD_PHARM,COUNTRY,CAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Canada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4420870,SCSUD_PHARM,COUNTRY,ECU,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ecuador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4439773,SCSUD_PHARM,COUNTRY,ISR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Israel,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4446934,SCSUD_PHARM,COUNTRY,KOR,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Korea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4458541,SCSUD_PHARM,COUNTRY,KOR,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Korea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4478645,SCSUD_PHARM,COUNTRY,SUR,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Suriname,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4483465,SCSUD_PHARM,COUNTRY,JAM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jamaica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4494344,SCSUD_PHARM,COUNTRY,EGY,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Egypt,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4495012,SCSUD_PHARM,COUNTRY,DEU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Germany,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4503479,SCSUD_PHARM,COUNTRY,MAR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Morocco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4519798,SCSUD_PHARM,COUNTRY,SWE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sweden,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4520645,SCSUD_PHARM,COUNTRY,SLV,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,El Salvador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4532930,SCSUD_PHARM,COUNTRY,THA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Thailand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4532941,SCSUD_PHARM,COUNTRY,SLV,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,El Salvador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4535533,SCSUD_PHARM,COUNTRY,SVK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovakia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4566095,SCSUD_PHARM,COUNTRY,BRA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Brazil,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4566380,SCSUD_PHARM,COUNTRY,AND,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Andorra,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4573070,SCSUD_PHARM,COUNTRY,FRA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,France,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4595404,SCSUD_PHARM,COUNTRY,POL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Poland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4602463,SCSUD_PHARM,COUNTRY,SLV,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,El Salvador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4609905,SCSUD_PHARM,COUNTRY,MAR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Morocco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4610198,SCSUD_PHARM,COUNTRY,PNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Papua New Guinea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4614785,SCSUD_PHARM,COUNTRY,LTU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Lithuania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4622123,SCSUD_PHARM,COUNTRY,NPL,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nepal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4623609,SCSUD_PHARM,COUNTRY,BWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Botswana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4627354,SCSUD_PHARM,COUNTRY,NIC,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nicaragua,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4639585,SCSUD_PHARM,COUNTRY,CHE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Switzerland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4646256,SCSUD_PHARM,COUNTRY,COD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Democratic Republic of the Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4661014,SCSUD_PHARM,COUNTRY,ITA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Italy,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4661480,SCSUD_PHARM,COUNTRY,NZL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,New Zealand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4686959,SCSUD_PHARM,COUNTRY,ZAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Africa,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4690410,SCSUD_PHARM,COUNTRY,SLE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sierra Leone,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4716209,SCSUD_PHARM,COUNTRY,SWZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Eswatini,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4717482,SCSUD_PHARM,COUNTRY,JOR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jordan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4747396,SCSUD_PHARM,COUNTRY,KNA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Kitts and Nevis,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4766272,SCSUD_PHARM,COUNTRY,GUY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guyana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4766953,SCSUD_PHARM,COUNTRY,TZA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Republic of Tanzania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4775283,SCSUD_PHARM,COUNTRY,MOZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mozambique,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4775490,SCSUD_PHARM,COUNTRY,BOL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bolivia (Plurinational State of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4775978,SCSUD_PHARM,COUNTRY,SRB,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Serbia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4800698,SCSUD_PHARM,COUNTRY,SSD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4805680,SCSUD_PHARM,COUNTRY,BWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Botswana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4812407,SCSUD_PHARM,COUNTRY,AGO,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Angola,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4812582,SCSUD_PHARM,COUNTRY,FRA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,France,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4812809,SCSUD_PHARM,COUNTRY,CYP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cyprus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4820456,SCSUD_PHARM,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saudi Arabia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4825235,SCSUD_PHARM,COUNTRY,MEX,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mexico,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4880757,SCSUD_PHARM,COUNTRY,KNA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Kitts and Nevis,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4896119,SCSUD_PHARM,COUNTRY,CAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Central African Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4925424,SCSUD_PHARM,COUNTRY,TJK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tajikistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4952827,SCSUD_PHARM,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Pakistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4959735,SCSUD_PHARM,COUNTRY,LVA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Latvia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4969581,SCSUD_PHARM,COUNTRY,ETH,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ethiopia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4970907,SCSUD_PHARM,COUNTRY,FRA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,France,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4984952,SCSUD_PHARM,COUNTRY,NGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nigeria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5022756,SCSUD_PHARM,COUNTRY,THA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Thailand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5033639,SCSUD_PHARM,COUNTRY,FRA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,France,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5047804,SCSUD_PHARM,COUNTRY,BLZ,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belize,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5048312,SCSUD_PHARM,COUNTRY,CUB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cuba,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5054213,SCSUD_PHARM,COUNTRY,CIV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cote d'Ivoire,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5065011,SCSUD_PHARM,COUNTRY,MEX,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mexico,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5077096,SCSUD_PHARM,COUNTRY,SWE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sweden,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5085716,SCSUD_PHARM,COUNTRY,IRN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iran (Islamic Republic of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5090795,SCSUD_PHARM,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tunisia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5103709,SCSUD_PHARM,COUNTRY,CPV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cabo Verde,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5105481,SCSUD_PHARM,COUNTRY,SYR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Syrian Arab Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5109881,SCSUD_PHARM,COUNTRY,LTU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Lithuania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5127613,SCSUD_PHARM,COUNTRY,BDI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burundi,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5130613,SCSUD_PHARM,COUNTRY,SVN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5149727,SCSUD_PHARM,COUNTRY,VUT,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Vanuatu,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5165631,SCSUD_PHARM,COUNTRY,VNM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Viet Nam,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5168355,SCSUD_PHARM,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Oman,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5180560,SCSUD_PHARM,COUNTRY,PRT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Portugal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5187331,SCSUD_PHARM,COUNTRY,COK,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cook Islands,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5191380,SCSUD_PHARM,COUNTRY,SVN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5197484,SCSUD_PHARM,COUNTRY,CAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Canada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5199017,SCSUD_PHARM,COUNTRY,FSM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Micronesia (Federated States of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5217376,SCSUD_PHARM,COUNTRY,GRD,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Grenada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5224213,SCSUD_PHARM,COUNTRY,HUN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Hungary,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5236258,SCSUD_PHARM,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tunisia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5254425,SCSUD_PHARM,COUNTRY,HUN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Hungary,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5254579,SCSUD_PHARM,COUNTRY,HUN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Hungary,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5254998,SCSUD_PHARM,COUNTRY,THA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Thailand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5273338,SCSUD_PHARM,COUNTRY,NLD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Netherlands (Kingdom of the),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5280995,SCSUD_PHARM,COUNTRY,DEU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Germany,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5286775,SCSUD_PHARM,COUNTRY,KHM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cambodia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5299315,SCSUD_PHARM,COUNTRY,ITA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Italy,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5307673,SCSUD_PHARM,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bahrain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5313364,SCSUD_PHARM,COUNTRY,MCO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Monaco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5313554,SCSUD_PHARM,COUNTRY,GHA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ghana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5324038,SCSUD_PHARM,COUNTRY,VCT,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5330397,SCSUD_PHARM,COUNTRY,CYP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cyprus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5330531,SCSUD_PHARM,COUNTRY,PRY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Paraguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5344951,SCSUD_PHARM,COUNTRY,SWZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Eswatini,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5345693,SCSUD_PHARM,COUNTRY,PNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Papua New Guinea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5349040,SCSUD_PHARM,COUNTRY,THA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Thailand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5350755,SCSUD_PHARM,COUNTRY,CHL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chile,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5351940,SCSUD_PHARM,COUNTRY,BTN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bhutan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5375500,SCSUD_PHARM,COUNTRY,COL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Colombia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5375571,SCSUD_PHARM,COUNTRY,SRB,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Serbia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5382342,SCSUD_PHARM,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Pakistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5388322,SCSUD_PHARM,COUNTRY,DNK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Denmark,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5389741,SCSUD_PHARM,COUNTRY,KAZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kazakhstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5400230,SCSUD_PHARM,COUNTRY,CHL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chile,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5408882,SCSUD_PHARM,COUNTRY,KOR,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Korea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5418661,SCSUD_PHARM,COUNTRY,PNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Papua New Guinea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5431838,SCSUD_PHARM,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Oman,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5433783,SCSUD_PHARM,COUNTRY,CAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Central African Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5483743,SCSUD_PHARM,COUNTRY,PNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Papua New Guinea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5490684,SCSUD_PHARM,COUNTRY,SVK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovakia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5495287,SCSUD_PHARM,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tunisia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5496294,SCSUD_PHARM,COUNTRY,MNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mongolia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5504369,SCSUD_PHARM,COUNTRY,SLV,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,El Salvador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5514491,SCSUD_PHARM,COUNTRY,THA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Thailand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5535500,SCSUD_PHARM,COUNTRY,NZL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,New Zealand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5553226,SCSUD_PHARM,COUNTRY,TKM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Turkmenistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5565314,SCSUD_PHARM,COUNTRY,CAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Canada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5570666,SCSUD_PHARM,COUNTRY,CUB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cuba,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5571835,SCSUD_PHARM,COUNTRY,CAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Central African Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5577001,SCSUD_PHARM,COUNTRY,NLD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Netherlands (Kingdom of the),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5577011,SCSUD_PHARM,COUNTRY,GUY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guyana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5577746,SCSUD_PHARM,COUNTRY,MMR,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Myanmar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5592491,SCSUD_PHARM,COUNTRY,TKM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Turkmenistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5609569,SCSUD_PHARM,COUNTRY,TON,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tonga,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5627420,SCSUD_PHARM,COUNTRY,BTN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bhutan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5628973,SCSUD_PHARM,COUNTRY,KGZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kyrgyzstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5647700,SCSUD_PHARM,COUNTRY,UGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uganda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5653251,SCSUD_PHARM,COUNTRY,COK,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cook Islands,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5666884,SCSUD_PHARM,COUNTRY,CUB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cuba,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5672770,SCSUD_PHARM,COUNTRY,KHM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cambodia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5673387,SCSUD_PHARM,COUNTRY,SRB,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Serbia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5705310,SCSUD_PHARM,COUNTRY,TUR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,TÃ¼rkiye,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5711334,SCSUD_PHARM,COUNTRY,EGY,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Egypt,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5723979,SCSUD_PHARM,COUNTRY,VNM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Viet Nam,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5735598,SCSUD_PHARM,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Oman,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5761854,SCSUD_PHARM,COUNTRY,LUX,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Luxembourg,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5762518,SCSUD_PHARM,COUNTRY,EGY,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Egypt,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5792866,SCSUD_PHARM,COUNTRY,MMR,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Myanmar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5794437,SCSUD_PHARM,COUNTRY,HND,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Honduras,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5807207,SCSUD_PHARM,COUNTRY,ROU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Romania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5812486,SCSUD_PHARM,COUNTRY,DMA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5830053,SCSUD_PHARM,COUNTRY,MKD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,North Macedonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5845513,SCSUD_PHARM,COUNTRY,LCA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Lucia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5857753,SCSUD_PHARM,COUNTRY,GEO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Georgia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5863582,SCSUD_PHARM,COUNTRY,JOR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jordan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5869518,SCSUD_PHARM,COUNTRY,LUX,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Luxembourg,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5882866,SCSUD_PHARM,COUNTRY,SSD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5883223,SCSUD_PHARM,COUNTRY,BEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Benin,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5887647,SCSUD_PHARM,COUNTRY,ECU,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ecuador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5900448,SCSUD_PHARM,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Oman,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5925874,SCSUD_PHARM,COUNTRY,MDA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Moldova,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5932095,SCSUD_PHARM,COUNTRY,BEL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belgium,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5937565,SCSUD_PHARM,COUNTRY,HRV,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Croatia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5937624,SCSUD_PHARM,COUNTRY,ZMB,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zambia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5938124,SCSUD_PHARM,COUNTRY,JPN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Japan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5969547,SCSUD_PHARM,COUNTRY,MEX,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mexico,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5976555,SCSUD_PHARM,COUNTRY,DOM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominican Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5988328,SCSUD_PHARM,COUNTRY,TUR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,TÃ¼rkiye,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5996186,SCSUD_PHARM,COUNTRY,QAT,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Qatar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6002813,SCSUD_PHARM,COUNTRY,NGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nigeria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6009276,SCSUD_PHARM,COUNTRY,SUR,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Suriname,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6019914,SCSUD_PHARM,COUNTRY,AFG,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Afghanistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6040731,SCSUD_PHARM,COUNTRY,RUS,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Russian Federation,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6041449,SCSUD_PHARM,COUNTRY,MYS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malaysia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6067498,SCSUD_PHARM,COUNTRY,LTU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Lithuania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6073787,SCSUD_PHARM,COUNTRY,SDN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6077678,SCSUD_PHARM,COUNTRY,DOM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominican Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6077999,SCSUD_PHARM,COUNTRY,LVA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Latvia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6085379,SCSUD_PHARM,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Pakistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6085946,SCSUD_PHARM,COUNTRY,JAM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jamaica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6096409,SCSUD_PHARM,COUNTRY,BLR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belarus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6103432,SCSUD_PHARM,COUNTRY,GRD,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Grenada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6108731,SCSUD_PHARM,COUNTRY,URY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uruguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6154362,SCSUD_PHARM,COUNTRY,CZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Czechia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6154644,SCSUD_PHARM,COUNTRY,SGP,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Singapore,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6166604,SCSUD_PHARM,COUNTRY,NOR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Norway,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6194313,SCSUD_PHARM,COUNTRY,CAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Central African Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6218959,SCSUD_PHARM,COUNTRY,VUT,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Vanuatu,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6223988,SCSUD_PHARM,COUNTRY,SLE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sierra Leone,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6231823,SCSUD_PHARM,COUNTRY,ROU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Romania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6244032,SCSUD_PHARM,COUNTRY,BRB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Barbados,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6249753,SCSUD_PHARM,COUNTRY,NZL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,New Zealand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6273571,SCSUD_PHARM,COUNTRY,URY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uruguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6276081,SCSUD_PHARM,COUNTRY,MKD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,North Macedonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6287818,SCSUD_PHARM,COUNTRY,MDA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Moldova,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6295056,SCSUD_PHARM,COUNTRY,BDI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burundi,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6298851,SCSUD_PHARM,COUNTRY,LBR,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Liberia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6300113,SCSUD_PHARM,COUNTRY,IRN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iran (Islamic Republic of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6306349,SCSUD_PHARM,COUNTRY,BEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Benin,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6306512,SCSUD_PHARM,COUNTRY,JOR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jordan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6311202,SCSUD_PHARM,COUNTRY,HND,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Honduras,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6325816,SCSUD_PHARM,COUNTRY,KOR,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Korea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6336487,SCSUD_PHARM,COUNTRY,EGY,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Egypt,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6337250,SCSUD_PHARM,COUNTRY,KEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kenya,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6343551,SCSUD_PHARM,COUNTRY,JAM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jamaica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6351169,SCSUD_PHARM,COUNTRY,COK,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cook Islands,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6370134,SCSUD_PHARM,COUNTRY,PNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Papua New Guinea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6371086,SCSUD_PHARM,COUNTRY,COG,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6390105,SCSUD_PHARM,COUNTRY,ISR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Israel,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6390133,SCSUD_PHARM,COUNTRY,ARM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Armenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6394136,SCSUD_PHARM,COUNTRY,AUS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Australia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6412623,SCSUD_PHARM,COUNTRY,CHN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,China,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6419079,SCSUD_PHARM,COUNTRY,CUB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cuba,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6446864,SCSUD_PHARM,COUNTRY,GHA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ghana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6460182,SCSUD_PHARM,COUNTRY,ZMB,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zambia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6463963,SCSUD_PHARM,COUNTRY,PRY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Paraguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6464858,SCSUD_PHARM,COUNTRY,UGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uganda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6464863,SCSUD_PHARM,COUNTRY,IRN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iran (Islamic Republic of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6464864,SCSUD_PHARM,COUNTRY,CIV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cote d'Ivoire,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6491402,SCSUD_PHARM,COUNTRY,KGZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kyrgyzstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6491776,SCSUD_PHARM,COUNTRY,MNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mongolia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6502762,SCSUD_PHARM,COUNTRY,BEL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belgium,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6546573,SCSUD_PHARM,COUNTRY,SVK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovakia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6573656,SCSUD_PHARM,COUNTRY,LCA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Lucia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6573704,SCSUD_PHARM,COUNTRY,COD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Democratic Republic of the Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6585544,SCSUD_PHARM,COUNTRY,NZL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,New Zealand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6590632,SCSUD_PHARM,COUNTRY,COD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Democratic Republic of the Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6596558,SCSUD_PHARM,COUNTRY,COL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Colombia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6598287,SCSUD_PHARM,COUNTRY,MLI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mali,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6602790,SCSUD_PHARM,COUNTRY,AUT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Austria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6602814,SCSUD_PHARM,COUNTRY,BLR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belarus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6603581,SCSUD_PHARM,COUNTRY,QAT,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Qatar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6616882,SCSUD_PHARM,COUNTRY,MYS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malaysia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6641634,SCSUD_PHARM,COUNTRY,VCT,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6643031,SCSUD_PHARM,COUNTRY,NPL,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nepal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6643696,SCSUD_PHARM,COUNTRY,CYP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cyprus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6646964,SCSUD_PHARM,COUNTRY,GHA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ghana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6650029,SCSUD_PHARM,COUNTRY,IRQ,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iraq,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6655823,SCSUD_PHARM,COUNTRY,IRN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iran (Islamic Republic of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6673904,SCSUD_PHARM,COUNTRY,RUS,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Russian Federation,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6680140,SCSUD_PHARM,COUNTRY,SUR,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Suriname,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6685420,SCSUD_PHARM,COUNTRY,AND,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Andorra,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6685749,SCSUD_PHARM,COUNTRY,KAZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kazakhstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6698258,SCSUD_PHARM,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Pakistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6762917,SCSUD_PHARM,COUNTRY,MOZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mozambique,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6777045,SCSUD_PHARM,COUNTRY,SLV,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,El Salvador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6777121,SCSUD_PHARM,COUNTRY,SEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Senegal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6783218,SCSUD_PHARM,COUNTRY,THA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Thailand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6787243,SCSUD_PHARM,COUNTRY,ZWE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zimbabwe,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6808869,SCSUD_PHARM,COUNTRY,FIN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Finland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6819809,SCSUD_PHARM,COUNTRY,CYP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cyprus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6825177,SCSUD_PHARM,COUNTRY,BOL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bolivia (Plurinational State of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6840530,SCSUD_PHARM,COUNTRY,TON,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tonga,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6846756,SCSUD_PHARM,COUNTRY,VCT,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6871977,SCSUD_PHARM,COUNTRY,GRC,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Greece,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6877376,SCSUD_PHARM,COUNTRY,TZA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Republic of Tanzania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6903830,SCSUD_PHARM,COUNTRY,GRC,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Greece,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6908206,SCSUD_PHARM,COUNTRY,NIC,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nicaragua,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6926988,SCSUD_PHARM,COUNTRY,ETH,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ethiopia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6928935,SCSUD_PHARM,COUNTRY,KEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kenya,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6938940,SCSUD_PHARM,COUNTRY,HND,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Honduras,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6946068,SCSUD_PHARM,COUNTRY,IRL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6948159,SCSUD_PHARM,COUNTRY,SLE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sierra Leone,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6957863,SCSUD_PHARM,COUNTRY,SVN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6984729,SCSUD_PHARM,COUNTRY,ISR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Israel,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7015150,SCSUD_PHARM,COUNTRY,MAR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Morocco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7015685,SCSUD_PHARM,COUNTRY,JAM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jamaica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7029895,SCSUD_PHARM,COUNTRY,ZMB,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zambia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7034370,SCSUD_PHARM,COUNTRY,MOZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mozambique,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7080264,SCSUD_PHARM,COUNTRY,CAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Central African Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7102777,SCSUD_PHARM,COUNTRY,COL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Colombia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7118557,SCSUD_PHARM,COUNTRY,TUR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,TÃ¼rkiye,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7144096,SCSUD_PHARM,COUNTRY,GHA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ghana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7147806,SCSUD_PHARM,COUNTRY,TON,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tonga,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7150204,SCSUD_PHARM,COUNTRY,CAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Canada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7167649,SCSUD_PHARM,COUNTRY,AUT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Austria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7169020,SCSUD_PHARM,COUNTRY,BEL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belgium,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7181339,SCSUD_PHARM,COUNTRY,POL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Poland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7199229,SCSUD_PHARM,COUNTRY,KGZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kyrgyzstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7200951,SCSUD_PHARM,COUNTRY,MLT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malta,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7200973,SCSUD_PHARM,COUNTRY,CHN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,China,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7210317,SCSUD_PHARM,COUNTRY,ZWE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zimbabwe,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7229482,SCSUD_PHARM,COUNTRY,UKR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ukraine,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7237196,SCSUD_PHARM,COUNTRY,CZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Czechia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7245143,SCSUD_PHARM,COUNTRY,UKR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ukraine,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7250657,SCSUD_PHARM,COUNTRY,AND,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Andorra,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7262079,SCSUD_PHARM,COUNTRY,TUR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,TÃ¼rkiye,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7263041,SCSUD_PHARM,COUNTRY,BEL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belgium,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7263199,SCSUD_PHARM,COUNTRY,BEL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belgium,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7274016,SCSUD_PHARM,COUNTRY,NOR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Norway,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7275243,SCSUD_PHARM,COUNTRY,AUS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Australia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7282775,SCSUD_PHARM,COUNTRY,DMA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7288976,SCSUD_PHARM,COUNTRY,DMA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7294568,SCSUD_PHARM,COUNTRY,KAZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kazakhstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7313889,SCSUD_PHARM,COUNTRY,SMR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,San Marino,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7314463,SCSUD_PHARM,COUNTRY,EST,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Estonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7318774,SCSUD_PHARM,COUNTRY,SWZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Eswatini,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7320908,SCSUD_PHARM,COUNTRY,KAZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kazakhstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7321210,SCSUD_PHARM,COUNTRY,MLT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malta,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7351199,SCSUD_PHARM,COUNTRY,KAZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kazakhstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7357003,SCSUD_PHARM,COUNTRY,LBR,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Liberia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7359285,SCSUD_PHARM,COUNTRY,VUT,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Vanuatu,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7363316,SCSUD_PHARM,COUNTRY,BWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Botswana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7378333,SCSUD_PHARM,COUNTRY,BOL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bolivia (Plurinational State of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7389897,SCSUD_PHARM,COUNTRY,SLE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sierra Leone,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7396364,SCSUD_PHARM,COUNTRY,GRC,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Greece,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7396890,SCSUD_PHARM,COUNTRY,KHM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cambodia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7414490,SCSUD_PHARM,COUNTRY,NIC,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nicaragua,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7423138,SCSUD_PHARM,COUNTRY,BGD,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bangladesh,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7426499,SCSUD_PHARM,COUNTRY,SSD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7440519,SCSUD_PHARM,COUNTRY,COK,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cook Islands,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7444956,SCSUD_PHARM,COUNTRY,KHM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cambodia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7451276,SCSUD_PHARM,COUNTRY,CRI,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Costa Rica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7452551,SCSUD_PHARM,COUNTRY,TCD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chad,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7453245,SCSUD_PHARM,COUNTRY,VNM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Viet Nam,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7492512,SCSUD_PHARM,COUNTRY,MOZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mozambique,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7498042,SCSUD_PHARM,COUNTRY,BRB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Barbados,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7511242,SCSUD_PHARM,COUNTRY,SMR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,San Marino,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7516275,SCSUD_PHARM,COUNTRY,PRT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Portugal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7521673,SCSUD_PHARM,COUNTRY,COK,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cook Islands,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7530495,SCSUD_PHARM,COUNTRY,GTM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guatemala,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7535874,SCSUD_PHARM,COUNTRY,MAR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Morocco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7547029,SCSUD_PHARM,COUNTRY,BRA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Brazil,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7556180,SCSUD_PHARM,COUNTRY,ISR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Israel,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7560745,SCSUD_PHARM,COUNTRY,AGO,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Angola,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7566737,SCSUD_PHARM,COUNTRY,HRV,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Croatia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7574036,SCSUD_PHARM,COUNTRY,LKA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sri Lanka,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7579172,SCSUD_PHARM,COUNTRY,ATG,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Antigua and Barbuda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7585069,SCSUD_PHARM,COUNTRY,SOM,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Somalia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7586409,SCSUD_PHARM,COUNTRY,GHA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ghana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7597316,SCSUD_PHARM,COUNTRY,TZA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Republic of Tanzania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7598359,SCSUD_PHARM,COUNTRY,SUR,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Suriname,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7611254,SCSUD_PHARM,COUNTRY,BWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Botswana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7625308,SCSUD_PHARM,COUNTRY,MCO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Monaco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7636282,SCSUD_PHARM,COUNTRY,UKR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ukraine,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7642504,SCSUD_PHARM,COUNTRY,AUS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Australia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7662219,SCSUD_PHARM,COUNTRY,SOM,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Somalia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7675281,SCSUD_PHARM,COUNTRY,ECU,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ecuador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7680025,SCSUD_PHARM,COUNTRY,BLZ,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belize,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7680954,SCSUD_PHARM,COUNTRY,CPV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cabo Verde,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7705481,SCSUD_PHARM,COUNTRY,CZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Czechia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7712446,SCSUD_PHARM,COUNTRY,BTN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bhutan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7719139,SCSUD_PHARM,COUNTRY,ETH,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ethiopia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7724873,SCSUD_PHARM,COUNTRY,SYR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Syrian Arab Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7758575,SCSUD_PHARM,COUNTRY,LKA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sri Lanka,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7758915,SCSUD_PHARM,COUNTRY,BOL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bolivia (Plurinational State of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7796295,SCSUD_PHARM,COUNTRY,AZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Azerbaijan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7807596,SCSUD_PHARM,COUNTRY,SUR,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Suriname,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7808015,SCSUD_PHARM,COUNTRY,TJK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tajikistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7812921,SCSUD_PHARM,COUNTRY,LVA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Latvia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7821990,SCSUD_PHARM,COUNTRY,ETH,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ethiopia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7833506,SCSUD_PHARM,COUNTRY,MNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mongolia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7834948,SCSUD_PHARM,COUNTRY,CHE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Switzerland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7863746,SCSUD_PHARM,COUNTRY,MKD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,North Macedonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7872396,SCSUD_PHARM,COUNTRY,DMA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7883285,SCSUD_PHARM,COUNTRY,PHL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Philippines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7884899,SCSUD_PHARM,COUNTRY,SEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Senegal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7896578,SCSUD_PHARM,COUNTRY,SYR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Syrian Arab Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7904178,SCSUD_PHARM,COUNTRY,HRV,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Croatia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7909604,SCSUD_PHARM,COUNTRY,IRQ,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iraq,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7916377,SCSUD_PHARM,COUNTRY,ZWE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zimbabwe,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7927281,SCSUD_PHARM,COUNTRY,SMR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,San Marino,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7941562,SCSUD_PHARM,COUNTRY,MEX,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mexico,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7954358,SCSUD_PHARM,COUNTRY,MYS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malaysia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7965553,SCSUD_PHARM,COUNTRY,AUS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Australia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7974759,SCSUD_PHARM,COUNTRY,AUS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Australia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7985260,SCSUD_PHARM,COUNTRY,SLV,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,El Salvador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7987309,SCSUD_PHARM,COUNTRY,KHM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cambodia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8005292,SCSUD_PHARM,COUNTRY,JPN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Japan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8037783,SCSUD_PHARM,COUNTRY,TJK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tajikistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8043342,SCSUD_PHARM,COUNTRY,SWE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sweden,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8048583,SCSUD_PHARM,COUNTRY,TZA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Republic of Tanzania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8068388,SCSUD_PHARM,COUNTRY,SLV,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,El Salvador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8081560,SCSUD_PHARM,COUNTRY,CUB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cuba,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8082589,SCSUD_PHARM,COUNTRY,SRB,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Serbia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8094243,SCSUD_PHARM,COUNTRY,POL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Poland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8099777,SCSUD_PHARM,COUNTRY,COL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Colombia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8119212,SCSUD_PHARM,COUNTRY,RUS,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Russian Federation,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8132197,SCSUD_PHARM,COUNTRY,SOM,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Somalia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8139784,SCSUD_PHARM,COUNTRY,COD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Democratic Republic of the Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8146264,SCSUD_PHARM,COUNTRY,CHN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,China,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8156774,SCSUD_PHARM,COUNTRY,SOM,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Somalia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8158727,SCSUD_PHARM,COUNTRY,GBR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8163627,SCSUD_PHARM,COUNTRY,CAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Canada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8195716,SCSUD_PHARM,COUNTRY,MNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mongolia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8207021,SCSUD_PHARM,COUNTRY,SMR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,San Marino,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8208254,SCSUD_PHARM,COUNTRY,MAR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Morocco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8215344,SCSUD_PHARM,COUNTRY,CRI,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Costa Rica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8220365,SCSUD_PHARM,COUNTRY,DEU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Germany,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8234042,SCSUD_PHARM,COUNTRY,SYC,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Seychelles,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8245222,SCSUD_PHARM,COUNTRY,CZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Czechia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8252392,SCSUD_PHARM,COUNTRY,BFA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burkina Faso,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8258620,SCSUD_PHARM,COUNTRY,CHN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,China,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8266598,SCSUD_PHARM,COUNTRY,DMA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8272880,SCSUD_PHARM,COUNTRY,HND,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Honduras,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8283389,SCSUD_PHARM,COUNTRY,UGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uganda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8285179,SCSUD_PHARM,COUNTRY,GUY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guyana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8336215,SCSUD_PHARM,COUNTRY,JOR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jordan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8346008,SCSUD_PHARM,COUNTRY,IND,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,India,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8352212,SCSUD_PHARM,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Pakistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8352778,SCSUD_PHARM,COUNTRY,MDA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Moldova,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8365521,SCSUD_PHARM,COUNTRY,RUS,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Russian Federation,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8371849,SCSUD_PHARM,COUNTRY,NPL,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nepal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8371941,SCSUD_PHARM,COUNTRY,IRQ,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iraq,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8385864,SCSUD_PHARM,COUNTRY,MDA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Moldova,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8390514,SCSUD_PHARM,COUNTRY,KOR,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Korea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8403776,SCSUD_PHARM,COUNTRY,BEL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belgium,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8417794,SCSUD_PHARM,COUNTRY,PRY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Paraguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8418662,SCSUD_PHARM,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saudi Arabia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8460137,SCSUD_PHARM,COUNTRY,ARM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Armenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8475668,SCSUD_PHARM,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Oman,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8511488,SCSUD_PHARM,COUNTRY,GRC,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Greece,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8511986,SCSUD_PHARM,COUNTRY,CPV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cabo Verde,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8513079,SCSUD_PHARM,COUNTRY,DNK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Denmark,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8513322,SCSUD_PHARM,COUNTRY,ZWE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zimbabwe,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8519436,SCSUD_PHARM,COUNTRY,DOM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominican Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8525200,SCSUD_PHARM,COUNTRY,PAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Panama,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8530700,SCSUD_PHARM,COUNTRY,IRL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8532456,SCSUD_PHARM,COUNTRY,PAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Panama,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8538204,SCSUD_PHARM,COUNTRY,BLZ,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belize,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8538900,SCSUD_PHARM,COUNTRY,PHL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Philippines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8539403,SCSUD_PHARM,COUNTRY,TZA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Republic of Tanzania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8570949,SCSUD_PHARM,COUNTRY,GEO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Georgia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8600644,SCSUD_PHARM,COUNTRY,EGY,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Egypt,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8618026,SCSUD_PHARM,COUNTRY,CIV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cote d'Ivoire,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8619893,SCSUD_PHARM,COUNTRY,BEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Benin,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8637414,SCSUD_PHARM,COUNTRY,TKM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Turkmenistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8639377,SCSUD_PHARM,COUNTRY,PAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Panama,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8657216,SCSUD_PHARM,COUNTRY,URY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uruguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8665207,SCSUD_PHARM,COUNTRY,LVA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Latvia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8670308,SCSUD_PHARM,COUNTRY,SGP,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Singapore,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8716291,SCSUD_PHARM,COUNTRY,CZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Czechia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8721518,SCSUD_PHARM,COUNTRY,CYP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cyprus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8731871,SCSUD_PHARM,COUNTRY,GUY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guyana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8733623,SCSUD_PHARM,COUNTRY,CHL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chile,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8740436,SCSUD_PHARM,COUNTRY,UGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uganda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8746680,SCSUD_PHARM,COUNTRY,SWZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Eswatini,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8757570,SCSUD_PHARM,COUNTRY,AND,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Andorra,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8764324,SCSUD_PHARM,COUNTRY,GEO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Georgia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8777221,SCSUD_PHARM,COUNTRY,PRT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Portugal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8783946,SCSUD_PHARM,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Oman,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8802369,SCSUD_PHARM,COUNTRY,PRY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Paraguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8803210,SCSUD_PHARM,COUNTRY,GRD,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Grenada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8808415,SCSUD_PHARM,COUNTRY,TKM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Turkmenistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8815903,SCSUD_PHARM,COUNTRY,BWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Botswana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8823460,SCSUD_PHARM,COUNTRY,BRB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Barbados,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8827895,SCSUD_PHARM,COUNTRY,CPV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cabo Verde,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8880104,SCSUD_PHARM,COUNTRY,ZAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Africa,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8916346,SCSUD_PHARM,COUNTRY,SLE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sierra Leone,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8928326,SCSUD_PHARM,COUNTRY,CAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Central African Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8935599,SCSUD_PHARM,COUNTRY,CUB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cuba,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8974184,SCSUD_PHARM,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Pakistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8981473,SCSUD_PHARM,COUNTRY,NLD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Netherlands (Kingdom of the),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9013745,SCSUD_PHARM,COUNTRY,BLR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belarus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9037074,SCSUD_PHARM,COUNTRY,DNK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Denmark,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9039586,SCSUD_PHARM,COUNTRY,DOM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominican Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9045009,SCSUD_PHARM,COUNTRY,SLV,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,El Salvador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9051055,SCSUD_PHARM,COUNTRY,FSM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Micronesia (Federated States of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9052065,SCSUD_PHARM,COUNTRY,CZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Czechia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9062750,SCSUD_PHARM,COUNTRY,MAR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Morocco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9077291,SCSUD_PHARM,COUNTRY,AFG,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Afghanistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9093609,SCSUD_PHARM,COUNTRY,SEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Senegal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9095605,SCSUD_PHARM,COUNTRY,SUR,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Suriname,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9108038,SCSUD_PHARM,COUNTRY,NIC,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nicaragua,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9132050,SCSUD_PHARM,COUNTRY,PHL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Philippines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9139303,SCSUD_PHARM,COUNTRY,AUT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Austria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9182938,SCSUD_PHARM,COUNTRY,RWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Rwanda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9188829,SCSUD_PHARM,COUNTRY,ESP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Spain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9195230,SCSUD_PHARM,COUNTRY,VNM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Viet Nam,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9196143,SCSUD_PHARM,COUNTRY,MMR,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Myanmar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9217341,SCSUD_PHARM,COUNTRY,DOM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominican Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9234177,SCSUD_PHARM,COUNTRY,IRL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9247361,SCSUD_PHARM,COUNTRY,TZA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Republic of Tanzania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9248721,SCSUD_PHARM,COUNTRY,FRA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,France,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9260420,SCSUD_PHARM,COUNTRY,SUR,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Suriname,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9266405,SCSUD_PHARM,COUNTRY,KAZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kazakhstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9272470,SCSUD_PHARM,COUNTRY,GTM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guatemala,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9290537,SCSUD_PHARM,COUNTRY,VNM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Viet Nam,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9297218,SCSUD_PHARM,COUNTRY,CPV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cabo Verde,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9302689,SCSUD_PHARM,COUNTRY,BRA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Brazil,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9305078,SCSUD_PHARM,COUNTRY,DMA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9317087,SCSUD_PHARM,COUNTRY,FSM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Micronesia (Federated States of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9322525,SCSUD_PHARM,COUNTRY,LKA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sri Lanka,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9342350,SCSUD_PHARM,COUNTRY,GRD,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Grenada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9359832,SCSUD_PHARM,COUNTRY,BGD,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bangladesh,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9367097,SCSUD_PHARM,COUNTRY,LUX,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Luxembourg,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9386459,SCSUD_PHARM,COUNTRY,MCO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Monaco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9404661,SCSUD_PHARM,COUNTRY,HUN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Hungary,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9429477,SCSUD_PHARM,COUNTRY,COK,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cook Islands,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9430425,SCSUD_PHARM,COUNTRY,BRA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Brazil,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9432754,SCSUD_PHARM,COUNTRY,GRD,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Grenada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9450132,SCSUD_PHARM,COUNTRY,CRI,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Costa Rica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9451075,SCSUD_PHARM,COUNTRY,ETH,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ethiopia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9456518,SCSUD_PHARM,COUNTRY,ISR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Israel,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9462998,SCSUD_PHARM,COUNTRY,MDA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Moldova,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9475421,SCSUD_PHARM,COUNTRY,SGP,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Singapore,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9506494,SCSUD_PHARM,COUNTRY,CAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Canada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9526201,SCSUD_PHARM,COUNTRY,CUB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cuba,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9531518,SCSUD_PHARM,COUNTRY,PHL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Philippines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9537065,SCSUD_PHARM,COUNTRY,ZMB,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zambia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9549242,SCSUD_PHARM,COUNTRY,SWZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Eswatini,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9550215,SCSUD_PHARM,COUNTRY,NGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nigeria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9558018,SCSUD_PHARM,COUNTRY,LBR,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Liberia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9562186,SCSUD_PHARM,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Oman,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9564224,SCSUD_PHARM,COUNTRY,LUX,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Luxembourg,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9568157,SCSUD_PHARM,COUNTRY,IRQ,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iraq,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9575269,SCSUD_PHARM,COUNTRY,BEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Benin,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9577850,SCSUD_PHARM,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tunisia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9581377,SCSUD_PHARM,COUNTRY,SWZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Eswatini,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9600095,SCSUD_PHARM,COUNTRY,NPL,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nepal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9606669,SCSUD_PHARM,COUNTRY,PRT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Portugal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9607159,SCSUD_PHARM,COUNTRY,LVA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Latvia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9613142,SCSUD_PHARM,COUNTRY,JOR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jordan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9613873,SCSUD_PHARM,COUNTRY,DNK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Denmark,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9619487,SCSUD_PHARM,COUNTRY,GRC,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Greece,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9633753,SCSUD_PHARM,COUNTRY,SGP,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Singapore,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9639415,SCSUD_PHARM,COUNTRY,SVN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9644701,SCSUD_PHARM,COUNTRY,HUN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Hungary,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9670208,SCSUD_PHARM,COUNTRY,MOZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mozambique,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9670656,SCSUD_PHARM,COUNTRY,BRA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Brazil,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9671082,SCSUD_PHARM,COUNTRY,BLR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belarus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9689210,SCSUD_PHARM,COUNTRY,GBR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9690508,SCSUD_PHARM,COUNTRY,CRI,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Costa Rica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9696007,SCSUD_PHARM,COUNTRY,BLR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belarus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9707742,SCSUD_PHARM,COUNTRY,COL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Colombia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9709170,SCSUD_PHARM,COUNTRY,BDI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burundi,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9716600,SCSUD_PHARM,COUNTRY,VCT,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9729400,SCSUD_PHARM,COUNTRY,TON,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tonga,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9733552,SCSUD_PHARM,COUNTRY,LKA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sri Lanka,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9740020,SCSUD_PHARM,COUNTRY,NOR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Norway,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9754949,SCSUD_PHARM,COUNTRY,BGD,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bangladesh,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9758498,SCSUD_PHARM,COUNTRY,HUN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Hungary,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9759416,SCSUD_PHARM,COUNTRY,LCA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Lucia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9759422,SCSUD_PHARM,COUNTRY,MLT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malta,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9779851,SCSUD_PHARM,COUNTRY,VNM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Viet Nam,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9798138,SCSUD_PHARM,COUNTRY,UGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uganda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9808880,SCSUD_PHARM,COUNTRY,KNA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Kitts and Nevis,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9809663,SCSUD_PHARM,COUNTRY,BFA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burkina Faso,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9817547,SCSUD_PHARM,COUNTRY,BOL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bolivia (Plurinational State of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9821205,SCSUD_PHARM,COUNTRY,LUX,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Luxembourg,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9823292,SCSUD_PHARM,COUNTRY,LTU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Lithuania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9848126,SCSUD_PHARM,COUNTRY,CUB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cuba,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9861939,SCSUD_PHARM,COUNTRY,KOR,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Korea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9867386,SCSUD_PHARM,COUNTRY,RUS,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Russian Federation,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9880610,SCSUD_PHARM,COUNTRY,EGY,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Egypt,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9880695,SCSUD_PHARM,COUNTRY,PHL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Philippines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9881151,SCSUD_PHARM,COUNTRY,VCT,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9887735,SCSUD_PHARM,COUNTRY,LVA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Latvia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9897413,SCSUD_PHARM,COUNTRY,EST,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Estonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9905026,SCSUD_PHARM,COUNTRY,ESP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Spain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9910768,SCSUD_PHARM,COUNTRY,SOM,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Somalia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9911312,SCSUD_PHARM,COUNTRY,VNM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Viet Nam,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9911575,SCSUD_PHARM,COUNTRY,IRN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iran (Islamic Republic of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9917743,SCSUD_PHARM,COUNTRY,ZMB,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zambia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9929593,SCSUD_PHARM,COUNTRY,JAM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jamaica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9941759,SCSUD_PHARM,COUNTRY,COG,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9948948,SCSUD_PHARM,COUNTRY,SRB,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Serbia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9962667,SCSUD_PHARM,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tunisia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9967965,SCSUD_PHARM,COUNTRY,LVA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Latvia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9979285,SCSUD_PHARM,COUNTRY,FRA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,France,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9980799,SCSUD_PHARM,COUNTRY,JAM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jamaica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10030050,SCSUD_PHARM,COUNTRY,IRN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iran (Islamic Republic of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10050061,SCSUD_PHARM,COUNTRY,CPV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cabo Verde,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10055635,SCSUD_PHARM,COUNTRY,SGP,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Singapore,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10070171,SCSUD_PHARM,COUNTRY,HND,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Honduras,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10074364,SCSUD_PHARM,COUNTRY,GTM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guatemala,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10076208,SCSUD_PHARM,COUNTRY,QAT,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Qatar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10077491,SCSUD_PHARM,COUNTRY,GEO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Georgia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10080797,SCSUD_PHARM,COUNTRY,LBR,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Liberia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10081941,SCSUD_PHARM,COUNTRY,VCT,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10106075,SCSUD_PHARM,COUNTRY,ITA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Italy,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10107338,SCSUD_PHARM,COUNTRY,POL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Poland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10114340,SCSUD_PHARM,COUNTRY,CHN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,China,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10121617,SCSUD_PHARM,COUNTRY,IND,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,India,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10134391,SCSUD_PHARM,COUNTRY,BRA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Brazil,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10152080,SCSUD_PHARM,COUNTRY,MEX,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mexico,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10164463,SCSUD_PHARM,COUNTRY,COD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Democratic Republic of the Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10759,SCSUD_PHARM,COUNTRY,GUY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guyana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
11990,SCSUD_PHARM,COUNTRY,PRY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Paraguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
49069,SCSUD_PHARM,COUNTRY,GTM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guatemala,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
51201,SCSUD_PHARM,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Pakistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
64006,SCSUD_PHARM,COUNTRY,ITA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Italy,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
68706,SCSUD_PHARM,COUNTRY,RWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Rwanda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
69099,SCSUD_PHARM,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Pakistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
69362,SCSUD_PHARM,COUNTRY,ITA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Italy,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
74435,SCSUD_PHARM,COUNTRY,SLE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sierra Leone,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
112006,SCSUD_PHARM,COUNTRY,THA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Thailand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
113568,SCSUD_PHARM,COUNTRY,ISR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Israel,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
125829,SCSUD_PHARM,COUNTRY,SEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Senegal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
152633,SCSUD_PHARM,COUNTRY,SYC,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Seychelles,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
158506,SCSUD_PHARM,COUNTRY,URY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uruguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
164489,SCSUD_PHARM,COUNTRY,GUY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guyana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
169966,SCSUD_PHARM,COUNTRY,POL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Poland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
219953,SCSUD_PHARM,COUNTRY,LUX,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Luxembourg,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
240908,SCSUD_PHARM,COUNTRY,ETH,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ethiopia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
245269,SCSUD_PHARM,COUNTRY,ZWE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zimbabwe,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
253124,SCSUD_PHARM,COUNTRY,SUR,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Suriname,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
253202,SCSUD_PHARM,COUNTRY,DOM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominican Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
265383,SCSUD_PHARM,COUNTRY,COG,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
270396,SCSUD_PHARM,COUNTRY,ECU,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ecuador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
270546,SCSUD_PHARM,COUNTRY,TKM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Turkmenistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
278315,SCSUD_PHARM,COUNTRY,JPN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Japan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
297821,SCSUD_PHARM,COUNTRY,BDI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burundi,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
308283,SCSUD_PHARM,COUNTRY,HND,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Honduras,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
345472,SCSUD_PHARM,COUNTRY,LCA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Lucia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
365184,SCSUD_PHARM,COUNTRY,AGO,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Angola,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
371544,SCSUD_PHARM,COUNTRY,IND,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,India,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
379052,SCSUD_PHARM,COUNTRY,BTN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bhutan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
392083,SCSUD_PHARM,COUNTRY,TON,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tonga,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
421106,SCSUD_PHARM,COUNTRY,NOR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Norway,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
434408,SCSUD_PHARM,COUNTRY,SYR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Syrian Arab Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
459592,SCSUD_PHARM,COUNTRY,RWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Rwanda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
466014,SCSUD_PHARM,COUNTRY,VCT,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
466303,SCSUD_PHARM,COUNTRY,CAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Central African Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
472604,SCSUD_PHARM,COUNTRY,MYS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malaysia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
479935,SCSUD_PHARM,COUNTRY,NIC,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nicaragua,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
486287,SCSUD_PHARM,COUNTRY,NGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nigeria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
506155,SCSUD_PHARM,COUNTRY,ARM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Armenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
529120,SCSUD_PHARM,COUNTRY,NLD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Netherlands (Kingdom of the),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
537583,SCSUD_PHARM,COUNTRY,IRL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
550115,SCSUD_PHARM,COUNTRY,VCT,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
592918,SCSUD_PHARM,COUNTRY,GUY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guyana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
598824,SCSUD_PHARM,COUNTRY,SSD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
617795,SCSUD_PHARM,COUNTRY,CYP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cyprus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
620293,SCSUD_PHARM,COUNTRY,ZWE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zimbabwe,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
636999,SCSUD_PHARM,COUNTRY,THA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Thailand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
658389,SCSUD_PHARM,COUNTRY,SRB,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Serbia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
701903,SCSUD_PHARM,COUNTRY,JPN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Japan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
707748,SCSUD_PHARM,COUNTRY,MAR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Morocco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
714765,SCSUD_PHARM,COUNTRY,MCO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Monaco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
721345,SCSUD_PHARM,COUNTRY,MLT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malta,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
757949,SCSUD_PHARM,COUNTRY,PRT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Portugal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
758767,SCSUD_PHARM,COUNTRY,MLT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malta,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
769571,SCSUD_PHARM,COUNTRY,ROU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Romania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
778594,SCSUD_PHARM,COUNTRY,LUX,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Luxembourg,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
834229,SCSUD_PHARM,COUNTRY,CZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Czechia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
846553,SCSUD_PHARM,COUNTRY,ZWE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zimbabwe,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
859766,SCSUD_PHARM,COUNTRY,RUS,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Russian Federation,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
861211,SCSUD_PHARM,COUNTRY,ATG,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Antigua and Barbuda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
865356,SCSUD_PHARM,COUNTRY,ECU,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ecuador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
878345,SCSUD_PHARM,COUNTRY,CHE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Switzerland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
878627,SCSUD_PHARM,COUNTRY,ZAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Africa,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
878982,SCSUD_PHARM,COUNTRY,SWZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Eswatini,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
892506,SCSUD_PHARM,COUNTRY,CHN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,China,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
903863,SCSUD_PHARM,COUNTRY,UKR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ukraine,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
910889,SCSUD_PHARM,COUNTRY,BFA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burkina Faso,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
937143,SCSUD_PHARM,COUNTRY,IND,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,India,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
954880,SCSUD_PHARM,COUNTRY,GHA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ghana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
966944,SCSUD_PHARM,COUNTRY,COG,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
967511,SCSUD_PHARM,COUNTRY,SDN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
987745,SCSUD_PHARM,COUNTRY,URY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uruguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
992563,SCSUD_PHARM,COUNTRY,CUB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cuba,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1008826,SCSUD_PHARM,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saudi Arabia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1014517,SCSUD_PHARM,COUNTRY,PNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Papua New Guinea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1019807,SCSUD_PHARM,COUNTRY,TKM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Turkmenistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1039301,SCSUD_PHARM,COUNTRY,GEO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Georgia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1053170,SCSUD_PHARM,COUNTRY,THA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Thailand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1077578,SCSUD_PHARM,COUNTRY,RWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Rwanda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1084026,SCSUD_PHARM,COUNTRY,CHE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Switzerland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1115287,SCSUD_PHARM,COUNTRY,PHL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Philippines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1122148,SCSUD_PHARM,COUNTRY,LBR,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Liberia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1123637,SCSUD_PHARM,COUNTRY,FIN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Finland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1136340,SCSUD_PHARM,COUNTRY,ECU,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ecuador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1148356,SCSUD_PHARM,COUNTRY,NIC,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nicaragua,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1160472,SCSUD_PHARM,COUNTRY,ROU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Romania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1167423,SCSUD_PHARM,COUNTRY,GUY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guyana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1178244,SCSUD_PHARM,COUNTRY,KHM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cambodia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1224958,SCSUD_PHARM,COUNTRY,AZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Azerbaijan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1236542,SCSUD_PHARM,COUNTRY,NOR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Norway,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1243400,SCSUD_PHARM,COUNTRY,ECU,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ecuador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1244199,SCSUD_PHARM,COUNTRY,SLV,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,El Salvador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1280176,SCSUD_PHARM,COUNTRY,SSD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1280700,SCSUD_PHARM,COUNTRY,URY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uruguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1280865,SCSUD_PHARM,COUNTRY,BRA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Brazil,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1287072,SCSUD_PHARM,COUNTRY,NZL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,New Zealand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1299269,SCSUD_PHARM,COUNTRY,GRC,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Greece,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1299729,SCSUD_PHARM,COUNTRY,NOR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Norway,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1313116,SCSUD_PHARM,COUNTRY,BDI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burundi,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1351115,SCSUD_PHARM,COUNTRY,BRA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Brazil,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1382858,SCSUD_PHARM,COUNTRY,CZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Czechia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1389521,SCSUD_PHARM,COUNTRY,BEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Benin,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1395523,SCSUD_PHARM,COUNTRY,BRA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Brazil,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1396327,SCSUD_PHARM,COUNTRY,KAZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kazakhstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1401994,SCSUD_PHARM,COUNTRY,BGD,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bangladesh,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1433090,SCSUD_PHARM,COUNTRY,ROU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Romania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1433763,SCSUD_PHARM,COUNTRY,ZAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Africa,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1434325,SCSUD_PHARM,COUNTRY,ESP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Spain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1446468,SCSUD_PHARM,COUNTRY,UKR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ukraine,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1471886,SCSUD_PHARM,COUNTRY,SVN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1482730,SCSUD_PHARM,COUNTRY,RWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Rwanda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1489576,SCSUD_PHARM,COUNTRY,COG,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1520918,SCSUD_PHARM,COUNTRY,LVA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Latvia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1533518,SCSUD_PHARM,COUNTRY,URY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uruguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1539551,SCSUD_PHARM,COUNTRY,MLT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malta,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1546011,SCSUD_PHARM,COUNTRY,NOR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Norway,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1571857,SCSUD_PHARM,COUNTRY,FSM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Micronesia (Federated States of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1596034,SCSUD_PHARM,COUNTRY,HUN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Hungary,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1598107,SCSUD_PHARM,COUNTRY,SEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Senegal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1622610,SCSUD_PHARM,COUNTRY,TCD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chad,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1623924,SCSUD_PHARM,COUNTRY,IDN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Indonesia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1634906,SCSUD_PHARM,COUNTRY,CAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Canada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1648289,SCSUD_PHARM,COUNTRY,SRB,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Serbia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1659870,SCSUD_PHARM,COUNTRY,BEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Benin,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1661603,SCSUD_PHARM,COUNTRY,CHL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chile,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1667186,SCSUD_PHARM,COUNTRY,AZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Azerbaijan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1672115,SCSUD_PHARM,COUNTRY,TUR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,TÃ¼rkiye,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1674193,SCSUD_PHARM,COUNTRY,SEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Senegal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1679164,SCSUD_PHARM,COUNTRY,DNK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Denmark,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1679462,SCSUD_PHARM,COUNTRY,NZL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,New Zealand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1706068,SCSUD_PHARM,COUNTRY,AFG,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Afghanistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1717591,SCSUD_PHARM,COUNTRY,EGY,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Egypt,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1750631,SCSUD_PHARM,COUNTRY,SMR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,San Marino,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1805904,SCSUD_PHARM,COUNTRY,RWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Rwanda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1813288,SCSUD_PHARM,COUNTRY,PER,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Peru,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1818532,SCSUD_PHARM,COUNTRY,CIV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cote d'Ivoire,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1819013,SCSUD_PHARM,COUNTRY,CYP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cyprus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1819176,SCSUD_PHARM,COUNTRY,UGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uganda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1831283,SCSUD_PHARM,COUNTRY,MCO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Monaco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1833037,SCSUD_PHARM,COUNTRY,ISR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Israel,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1844549,SCSUD_PHARM,COUNTRY,SYC,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Seychelles,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1845650,SCSUD_PHARM,COUNTRY,ZAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Africa,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1855963,SCSUD_PHARM,COUNTRY,SVN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1857041,SCSUD_PHARM,COUNTRY,AGO,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Angola,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1875243,SCSUD_PHARM,COUNTRY,DEU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Germany,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1888895,SCSUD_PHARM,COUNTRY,EST,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Estonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1921630,SCSUD_PHARM,COUNTRY,SVN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1933200,SCSUD_PHARM,COUNTRY,SYR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Syrian Arab Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1945450,SCSUD_PHARM,COUNTRY,SLE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sierra Leone,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1959298,SCSUD_PHARM,COUNTRY,LUX,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Luxembourg,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
1983619,SCSUD_PHARM,COUNTRY,NIC,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nicaragua,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2034578,SCSUD_PHARM,COUNTRY,CHE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Switzerland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2038892,SCSUD_PHARM,COUNTRY,CPV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cabo Verde,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2071733,SCSUD_PHARM,COUNTRY,ISR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Israel,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2072488,SCSUD_PHARM,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bahrain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2090272,SCSUD_PHARM,COUNTRY,KEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kenya,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2102773,SCSUD_PHARM,COUNTRY,SGP,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Singapore,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2109648,SCSUD_PHARM,COUNTRY,ISL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iceland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2184885,SCSUD_PHARM,COUNTRY,MAR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Morocco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2185335,SCSUD_PHARM,COUNTRY,TUR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,TÃ¼rkiye,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2198267,SCSUD_PHARM,COUNTRY,ISL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iceland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2212681,SCSUD_PHARM,COUNTRY,BWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Botswana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2212741,SCSUD_PHARM,COUNTRY,MCO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Monaco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2225480,SCSUD_PHARM,COUNTRY,GBR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2247944,SCSUD_PHARM,COUNTRY,SMR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,San Marino,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2266995,SCSUD_PHARM,COUNTRY,MEX,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mexico,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2273373,SCSUD_PHARM,COUNTRY,AUT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Austria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2288438,SCSUD_PHARM,COUNTRY,AND,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Andorra,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2305017,SCSUD_PHARM,COUNTRY,ISL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iceland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2330658,SCSUD_PHARM,COUNTRY,BFA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burkina Faso,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2332724,SCSUD_PHARM,COUNTRY,BEL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belgium,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2364917,SCSUD_PHARM,COUNTRY,GTM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guatemala,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2369513,SCSUD_PHARM,COUNTRY,ESP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Spain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2376577,SCSUD_PHARM,COUNTRY,TCD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chad,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2383132,SCSUD_PHARM,COUNTRY,NZL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,New Zealand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2407797,SCSUD_PHARM,COUNTRY,ZMB,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zambia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2414082,SCSUD_PHARM,COUNTRY,SYR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Syrian Arab Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2414268,SCSUD_PHARM,COUNTRY,TJK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tajikistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2439287,SCSUD_PHARM,COUNTRY,RUS,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Russian Federation,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2450948,SCSUD_PHARM,COUNTRY,CPV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cabo Verde,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2458766,SCSUD_PHARM,COUNTRY,DMA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2476796,SCSUD_PHARM,COUNTRY,SVK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovakia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2489375,SCSUD_PHARM,COUNTRY,NPL,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nepal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2501221,SCSUD_PHARM,COUNTRY,SMR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,San Marino,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2507709,SCSUD_PHARM,COUNTRY,LBR,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Liberia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2509653,SCSUD_PHARM,COUNTRY,TON,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tonga,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2514699,SCSUD_PHARM,COUNTRY,BGD,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bangladesh,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2520951,SCSUD_PHARM,COUNTRY,VUT,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Vanuatu,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2545958,SCSUD_PHARM,COUNTRY,MMR,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Myanmar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2546758,SCSUD_PHARM,COUNTRY,CAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Canada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2577398,SCSUD_PHARM,COUNTRY,MLI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mali,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2579376,SCSUD_PHARM,COUNTRY,MMR,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Myanmar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2602767,SCSUD_PHARM,COUNTRY,MMR,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Myanmar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2609737,SCSUD_PHARM,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Oman,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2629531,SCSUD_PHARM,COUNTRY,PHL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Philippines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2629953,SCSUD_PHARM,COUNTRY,PER,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Peru,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2667532,SCSUD_PHARM,COUNTRY,CAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Canada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2668434,SCSUD_PHARM,COUNTRY,PRT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Portugal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2699830,SCSUD_PHARM,COUNTRY,GHA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ghana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2718552,SCSUD_PHARM,COUNTRY,RUS,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Russian Federation,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2743223,SCSUD_PHARM,COUNTRY,ZMB,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zambia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2756092,SCSUD_PHARM,COUNTRY,SVK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovakia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2769210,SCSUD_PHARM,COUNTRY,QAT,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Qatar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2774675,SCSUD_PHARM,COUNTRY,SOM,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Somalia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2780841,SCSUD_PHARM,COUNTRY,TJK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tajikistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2788098,SCSUD_PHARM,COUNTRY,ATG,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Antigua and Barbuda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2795477,SCSUD_PHARM,COUNTRY,IRN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iran (Islamic Republic of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2799763,SCSUD_PHARM,COUNTRY,ISL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iceland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2832007,SCSUD_PHARM,COUNTRY,LVA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Latvia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2833760,SCSUD_PHARM,COUNTRY,TJK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tajikistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2838864,SCSUD_PHARM,COUNTRY,KNA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Kitts and Nevis,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2843716,SCSUD_PHARM,COUNTRY,TUR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,TÃ¼rkiye,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2862474,SCSUD_PHARM,COUNTRY,MOZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mozambique,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2862550,SCSUD_PHARM,COUNTRY,GEO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Georgia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2881405,SCSUD_PHARM,COUNTRY,AND,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Andorra,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2882995,SCSUD_PHARM,COUNTRY,IRQ,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iraq,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2887664,SCSUD_PHARM,COUNTRY,IRQ,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iraq,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2893848,SCSUD_PHARM,COUNTRY,AUS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Australia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2894779,SCSUD_PHARM,COUNTRY,UKR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ukraine,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2927569,SCSUD_PHARM,COUNTRY,ZWE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zimbabwe,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2950810,SCSUD_PHARM,COUNTRY,BRB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Barbados,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2958467,SCSUD_PHARM,COUNTRY,MOZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mozambique,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2966179,SCSUD_PHARM,COUNTRY,CYP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cyprus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2972288,SCSUD_PHARM,COUNTRY,BTN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bhutan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2989536,SCSUD_PHARM,COUNTRY,CHE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Switzerland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2995214,SCSUD_PHARM,COUNTRY,GUY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guyana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
2995758,SCSUD_PHARM,COUNTRY,GRC,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Greece,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3003834,SCSUD_PHARM,COUNTRY,NIC,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nicaragua,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3009302,SCSUD_PHARM,COUNTRY,MAR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Morocco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3014032,SCSUD_PHARM,COUNTRY,MCO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Monaco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3027906,SCSUD_PHARM,COUNTRY,HRV,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Croatia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3033923,SCSUD_PHARM,COUNTRY,AND,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Andorra,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3039239,SCSUD_PHARM,COUNTRY,LBR,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Liberia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3048050,SCSUD_PHARM,COUNTRY,UGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uganda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3064763,SCSUD_PHARM,COUNTRY,BRA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Brazil,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3071223,SCSUD_PHARM,COUNTRY,MEX,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mexico,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3078404,SCSUD_PHARM,COUNTRY,MDA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Moldova,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3079319,SCSUD_PHARM,COUNTRY,POL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Poland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3085080,SCSUD_PHARM,COUNTRY,CPV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cabo Verde,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3091550,SCSUD_PHARM,COUNTRY,HRV,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Croatia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3111955,SCSUD_PHARM,COUNTRY,LCA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Lucia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3116788,SCSUD_PHARM,COUNTRY,SRB,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Serbia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3117447,SCSUD_PHARM,COUNTRY,MYS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malaysia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3130899,SCSUD_PHARM,COUNTRY,CHL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chile,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3143414,SCSUD_PHARM,COUNTRY,TON,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tonga,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3153892,SCSUD_PHARM,COUNTRY,MNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mongolia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3167287,SCSUD_PHARM,COUNTRY,AGO,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Angola,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3181198,SCSUD_PHARM,COUNTRY,BOL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bolivia (Plurinational State of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3224846,SCSUD_PHARM,COUNTRY,FIN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Finland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3230692,SCSUD_PHARM,COUNTRY,ECU,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ecuador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3263208,SCSUD_PHARM,COUNTRY,SLV,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,El Salvador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3268809,SCSUD_PHARM,COUNTRY,VNM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Viet Nam,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3269265,SCSUD_PHARM,COUNTRY,DNK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Denmark,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3274956,SCSUD_PHARM,COUNTRY,RUS,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Russian Federation,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3287612,SCSUD_PHARM,COUNTRY,HND,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Honduras,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3288517,SCSUD_PHARM,COUNTRY,HRV,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Croatia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3294324,SCSUD_PHARM,COUNTRY,ESP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Spain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3295983,SCSUD_PHARM,COUNTRY,AFG,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Afghanistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3302334,SCSUD_PHARM,COUNTRY,ZAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Africa,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3313752,SCSUD_PHARM,COUNTRY,BDI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burundi,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3325645,SCSUD_PHARM,COUNTRY,GRD,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Grenada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3338316,SCSUD_PHARM,COUNTRY,RWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Rwanda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3340359,SCSUD_PHARM,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bahrain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3358657,SCSUD_PHARM,COUNTRY,SWE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sweden,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3364172,SCSUD_PHARM,COUNTRY,EST,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Estonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3371885,SCSUD_PHARM,COUNTRY,DOM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominican Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3378675,SCSUD_PHARM,COUNTRY,BLZ,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belize,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3391213,SCSUD_PHARM,COUNTRY,AUS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Australia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3420542,SCSUD_PHARM,COUNTRY,JPN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Japan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3433921,SCSUD_PHARM,COUNTRY,TUR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,TÃ¼rkiye,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3464594,SCSUD_PHARM,COUNTRY,KEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kenya,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3464860,SCSUD_PHARM,COUNTRY,GRC,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Greece,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3466989,SCSUD_PHARM,COUNTRY,SVN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3472676,SCSUD_PHARM,COUNTRY,BRB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Barbados,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3473445,SCSUD_PHARM,COUNTRY,ARM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Armenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3477803,SCSUD_PHARM,COUNTRY,PER,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Peru,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3483841,SCSUD_PHARM,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saudi Arabia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3483995,SCSUD_PHARM,COUNTRY,FIN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Finland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3497433,SCSUD_PHARM,COUNTRY,KEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kenya,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3498278,SCSUD_PHARM,COUNTRY,NZL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,New Zealand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3522248,SCSUD_PHARM,COUNTRY,SWE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sweden,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3559357,SCSUD_PHARM,COUNTRY,FRA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,France,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3565482,SCSUD_PHARM,COUNTRY,PAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Panama,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3574499,SCSUD_PHARM,COUNTRY,POL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Poland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3579021,SCSUD_PHARM,COUNTRY,TJK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tajikistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3585884,SCSUD_PHARM,COUNTRY,MDA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Moldova,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3586950,SCSUD_PHARM,COUNTRY,TZA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Republic of Tanzania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3603597,SCSUD_PHARM,COUNTRY,VNM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Viet Nam,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3604093,SCSUD_PHARM,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tunisia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3616678,SCSUD_PHARM,COUNTRY,FSM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Micronesia (Federated States of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3622833,SCSUD_PHARM,COUNTRY,JOR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jordan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3624444,SCSUD_PHARM,COUNTRY,LTU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Lithuania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3630385,SCSUD_PHARM,COUNTRY,COD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Democratic Republic of the Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3636557,SCSUD_PHARM,COUNTRY,BWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Botswana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3655565,SCSUD_PHARM,COUNTRY,TUR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,TÃ¼rkiye,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3661140,SCSUD_PHARM,COUNTRY,MMR,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Myanmar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3667671,SCSUD_PHARM,COUNTRY,COL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Colombia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3694194,SCSUD_PHARM,COUNTRY,EST,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Estonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3699331,SCSUD_PHARM,COUNTRY,SSD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3749928,SCSUD_PHARM,COUNTRY,MAR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Morocco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3757222,SCSUD_PHARM,COUNTRY,VNM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Viet Nam,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3768743,SCSUD_PHARM,COUNTRY,QAT,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Qatar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3781293,SCSUD_PHARM,COUNTRY,IRL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3782106,SCSUD_PHARM,COUNTRY,KEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kenya,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3786274,SCSUD_PHARM,COUNTRY,GBR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3800454,SCSUD_PHARM,COUNTRY,COK,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cook Islands,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3808027,SCSUD_PHARM,COUNTRY,KHM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cambodia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3824390,SCSUD_PHARM,COUNTRY,NLD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Netherlands (Kingdom of the),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3839328,SCSUD_PHARM,COUNTRY,DEU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Germany,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3844130,SCSUD_PHARM,COUNTRY,IRL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3848822,SCSUD_PHARM,COUNTRY,MEX,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mexico,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3881600,SCSUD_PHARM,COUNTRY,BWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Botswana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3883049,SCSUD_PHARM,COUNTRY,PRY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Paraguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3907181,SCSUD_PHARM,COUNTRY,GEO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Georgia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3914573,SCSUD_PHARM,COUNTRY,NIC,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nicaragua,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3918518,SCSUD_PHARM,COUNTRY,MLI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mali,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3919283,SCSUD_PHARM,COUNTRY,UGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uganda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3926076,SCSUD_PHARM,COUNTRY,DOM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominican Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3931769,SCSUD_PHARM,COUNTRY,AZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Azerbaijan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3933102,SCSUD_PHARM,COUNTRY,ZAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Africa,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3939136,SCSUD_PHARM,COUNTRY,NOR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Norway,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3948942,SCSUD_PHARM,COUNTRY,SYR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Syrian Arab Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3949417,SCSUD_PHARM,COUNTRY,COD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Democratic Republic of the Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3961090,SCSUD_PHARM,COUNTRY,TZA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Republic of Tanzania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3961706,SCSUD_PHARM,COUNTRY,NIC,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nicaragua,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3961816,SCSUD_PHARM,COUNTRY,ARM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Armenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3986002,SCSUD_PHARM,COUNTRY,JPN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Japan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
3998757,SCSUD_PHARM,COUNTRY,SMR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,San Marino,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4004302,SCSUD_PHARM,COUNTRY,CRI,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Costa Rica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4010951,SCSUD_PHARM,COUNTRY,ROU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Romania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4017150,SCSUD_PHARM,COUNTRY,CZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Czechia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4023799,SCSUD_PHARM,COUNTRY,ETH,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ethiopia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4031632,SCSUD_PHARM,COUNTRY,SEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Senegal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4062263,SCSUD_PHARM,COUNTRY,EST,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Estonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4119792,SCSUD_PHARM,COUNTRY,GBR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4162462,SCSUD_PHARM,COUNTRY,AUS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Australia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4162769,SCSUD_PHARM,COUNTRY,TON,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tonga,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4182089,SCSUD_PHARM,COUNTRY,ECU,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ecuador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4189236,SCSUD_PHARM,COUNTRY,MDA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Moldova,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4189447,SCSUD_PHARM,COUNTRY,SOM,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Somalia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4207374,SCSUD_PHARM,COUNTRY,IRQ,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iraq,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4232352,SCSUD_PHARM,COUNTRY,ISL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iceland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4252570,SCSUD_PHARM,COUNTRY,FIN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Finland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4258235,SCSUD_PHARM,COUNTRY,ROU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Romania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4277042,SCSUD_PHARM,COUNTRY,ETH,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ethiopia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4297360,SCSUD_PHARM,COUNTRY,IRN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iran (Islamic Republic of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4297688,SCSUD_PHARM,COUNTRY,ISL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iceland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4341254,SCSUD_PHARM,COUNTRY,DOM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominican Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4359982,SCSUD_PHARM,COUNTRY,KGZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kyrgyzstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4373544,SCSUD_PHARM,COUNTRY,SVN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4392248,SCSUD_PHARM,COUNTRY,NGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nigeria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4392450,SCSUD_PHARM,COUNTRY,AZE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Azerbaijan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4392634,SCSUD_PHARM,COUNTRY,ZWE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zimbabwe,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4404739,SCSUD_PHARM,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saudi Arabia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4418047,SCSUD_PHARM,COUNTRY,MMR,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Myanmar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4456020,SCSUD_PHARM,COUNTRY,ITA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Italy,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4461044,SCSUD_PHARM,COUNTRY,EGY,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Egypt,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4466209,SCSUD_PHARM,COUNTRY,FIN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Finland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4504113,SCSUD_PHARM,COUNTRY,UKR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ukraine,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4517907,SCSUD_PHARM,COUNTRY,HND,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Honduras,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4518410,SCSUD_PHARM,COUNTRY,DNK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Denmark,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4530658,SCSUD_PHARM,COUNTRY,DEU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Germany,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4530980,SCSUD_PHARM,COUNTRY,KNA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Kitts and Nevis,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4543045,SCSUD_PHARM,COUNTRY,SUR,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Suriname,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4600541,SCSUD_PHARM,COUNTRY,GRD,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Grenada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4607142,SCSUD_PHARM,COUNTRY,SLE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sierra Leone,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4618998,SCSUD_PHARM,COUNTRY,AUT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Austria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4637507,SCSUD_PHARM,COUNTRY,MNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mongolia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4637584,SCSUD_PHARM,COUNTRY,KHM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cambodia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4637744,SCSUD_PHARM,COUNTRY,JPN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Japan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4709109,SCSUD_PHARM,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tunisia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4721053,SCSUD_PHARM,COUNTRY,SDN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4732050,SCSUD_PHARM,COUNTRY,RUS,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Russian Federation,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4784926,SCSUD_PHARM,COUNTRY,SYC,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Seychelles,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4808294,SCSUD_PHARM,COUNTRY,NPL,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nepal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4809007,SCSUD_PHARM,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Pakistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4820727,SCSUD_PHARM,COUNTRY,PRT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Portugal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4823102,SCSUD_PHARM,COUNTRY,ISR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Israel,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4840870,SCSUD_PHARM,COUNTRY,BFA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burkina Faso,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4865278,SCSUD_PHARM,COUNTRY,JPN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Japan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4879306,SCSUD_PHARM,COUNTRY,BRB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Barbados,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4885164,SCSUD_PHARM,COUNTRY,SVN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4891695,SCSUD_PHARM,COUNTRY,CHL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chile,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4896980,SCSUD_PHARM,COUNTRY,KEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kenya,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4904507,SCSUD_PHARM,COUNTRY,ITA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Italy,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4936293,SCSUD_PHARM,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bahrain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4954497,SCSUD_PHARM,COUNTRY,MNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mongolia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4961398,SCSUD_PHARM,COUNTRY,CHN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,China,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
4967081,SCSUD_PHARM,COUNTRY,TCD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chad,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5000547,SCSUD_PHARM,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bahrain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5037091,SCSUD_PHARM,COUNTRY,ESP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Spain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5044395,SCSUD_PHARM,COUNTRY,AGO,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Angola,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5055651,SCSUD_PHARM,COUNTRY,CYP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cyprus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5055877,SCSUD_PHARM,COUNTRY,MOZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mozambique,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5076399,SCSUD_PHARM,COUNTRY,AFG,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Afghanistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5095692,SCSUD_PHARM,COUNTRY,IDN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Indonesia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5114121,SCSUD_PHARM,COUNTRY,ARM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Armenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5118899,SCSUD_PHARM,COUNTRY,PAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Panama,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5146162,SCSUD_PHARM,COUNTRY,SLE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sierra Leone,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5150193,SCSUD_PHARM,COUNTRY,MAR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Morocco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5156617,SCSUD_PHARM,COUNTRY,UKR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ukraine,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5169239,SCSUD_PHARM,COUNTRY,KEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kenya,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5178034,SCSUD_PHARM,COUNTRY,HRV,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Croatia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5190567,SCSUD_PHARM,COUNTRY,SVK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovakia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5195596,SCSUD_PHARM,COUNTRY,PRY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Paraguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5201655,SCSUD_PHARM,COUNTRY,VUT,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Vanuatu,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5208859,SCSUD_PHARM,COUNTRY,JPN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Japan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5208980,SCSUD_PHARM,COUNTRY,LBR,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Liberia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5209363,SCSUD_PHARM,COUNTRY,SYR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Syrian Arab Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5232880,SCSUD_PHARM,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bahrain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5265744,SCSUD_PHARM,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bahrain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5283813,SCSUD_PHARM,COUNTRY,PRT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Portugal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5302865,SCSUD_PHARM,COUNTRY,KGZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kyrgyzstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5340445,SCSUD_PHARM,COUNTRY,GBR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5359570,SCSUD_PHARM,COUNTRY,LVA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Latvia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5371526,SCSUD_PHARM,COUNTRY,LTU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Lithuania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5391988,SCSUD_PHARM,COUNTRY,GRD,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Grenada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5392792,SCSUD_PHARM,COUNTRY,NLD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Netherlands (Kingdom of the),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5403429,SCSUD_PHARM,COUNTRY,GEO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Georgia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5422777,SCSUD_PHARM,COUNTRY,IND,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,India,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5429361,SCSUD_PHARM,COUNTRY,BRA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Brazil,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5435730,SCSUD_PHARM,COUNTRY,SEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Senegal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5436261,SCSUD_PHARM,COUNTRY,CAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Central African Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5443055,SCSUD_PHARM,COUNTRY,MEX,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mexico,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5466628,SCSUD_PHARM,COUNTRY,IRQ,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iraq,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5467366,SCSUD_PHARM,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tunisia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5473395,SCSUD_PHARM,COUNTRY,PHL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Philippines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5500372,SCSUD_PHARM,COUNTRY,ISL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iceland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5518414,SCSUD_PHARM,COUNTRY,SOM,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Somalia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5526256,SCSUD_PHARM,COUNTRY,MKD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,North Macedonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5532432,SCSUD_PHARM,COUNTRY,ATG,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Antigua and Barbuda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5555696,SCSUD_PHARM,COUNTRY,MKD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,North Macedonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5557565,SCSUD_PHARM,COUNTRY,NZL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,New Zealand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5606918,SCSUD_PHARM,COUNTRY,TZA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Republic of Tanzania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5607383,SCSUD_PHARM,COUNTRY,CHL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chile,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5613293,SCSUD_PHARM,COUNTRY,BTN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bhutan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5620103,SCSUD_PHARM,COUNTRY,POL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Poland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5620893,SCSUD_PHARM,COUNTRY,MMR,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Myanmar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5621032,SCSUD_PHARM,COUNTRY,GUY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guyana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5630889,SCSUD_PHARM,COUNTRY,EST,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Estonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5663833,SCSUD_PHARM,COUNTRY,ROU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Romania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5664533,SCSUD_PHARM,COUNTRY,BRB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Barbados,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5677512,SCSUD_PHARM,COUNTRY,GTM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guatemala,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5687832,SCSUD_PHARM,COUNTRY,ISL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iceland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5745173,SCSUD_PHARM,COUNTRY,MCO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Monaco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5746389,SCSUD_PHARM,COUNTRY,PHL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Philippines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5751182,SCSUD_PHARM,COUNTRY,GTM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guatemala,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5758325,SCSUD_PHARM,COUNTRY,SSD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5789801,SCSUD_PHARM,COUNTRY,VCT,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5791056,SCSUD_PHARM,COUNTRY,LKA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sri Lanka,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5797959,SCSUD_PHARM,COUNTRY,ITA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Italy,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5809213,SCSUD_PHARM,COUNTRY,LKA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sri Lanka,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5827057,SCSUD_PHARM,COUNTRY,HUN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Hungary,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5828557,SCSUD_PHARM,COUNTRY,CYP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cyprus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5846189,SCSUD_PHARM,COUNTRY,VUT,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Vanuatu,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5884860,SCSUD_PHARM,COUNTRY,CIV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cote d'Ivoire,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5909314,SCSUD_PHARM,COUNTRY,QAT,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Qatar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5916202,SCSUD_PHARM,COUNTRY,BRA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Brazil,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5922001,SCSUD_PHARM,COUNTRY,ATG,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Antigua and Barbuda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5934574,SCSUD_PHARM,COUNTRY,LBR,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Liberia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5949049,SCSUD_PHARM,COUNTRY,MLI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mali,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5949118,SCSUD_PHARM,COUNTRY,CUB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cuba,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5978784,SCSUD_PHARM,COUNTRY,MDA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Moldova,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
5999453,SCSUD_PHARM,COUNTRY,AUT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Austria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6005526,SCSUD_PHARM,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bahrain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6037280,SCSUD_PHARM,COUNTRY,SRB,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Serbia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6042767,SCSUD_PHARM,COUNTRY,MNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mongolia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6049834,SCSUD_PHARM,COUNTRY,SEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Senegal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6055387,SCSUD_PHARM,COUNTRY,EST,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Estonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6056403,SCSUD_PHARM,COUNTRY,UKR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ukraine,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6081012,SCSUD_PHARM,COUNTRY,SVK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovakia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6081797,SCSUD_PHARM,COUNTRY,PRY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Paraguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6089387,SCSUD_PHARM,COUNTRY,JPN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Japan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6112524,SCSUD_PHARM,COUNTRY,TJK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tajikistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6120885,SCSUD_PHARM,COUNTRY,CAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Canada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6127584,SCSUD_PHARM,COUNTRY,POL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Poland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6143747,SCSUD_PHARM,COUNTRY,MLI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mali,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6163667,SCSUD_PHARM,COUNTRY,NPL,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nepal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6181827,SCSUD_PHARM,COUNTRY,KOR,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Korea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6183072,SCSUD_PHARM,COUNTRY,FRA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,France,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6189863,SCSUD_PHARM,COUNTRY,JAM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jamaica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6209634,SCSUD_PHARM,COUNTRY,BGD,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bangladesh,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6214446,SCSUD_PHARM,COUNTRY,HRV,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Croatia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6253699,SCSUD_PHARM,COUNTRY,KHM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cambodia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6258640,SCSUD_PHARM,COUNTRY,THA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Thailand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6259231,SCSUD_PHARM,COUNTRY,SOM,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Somalia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6272455,SCSUD_PHARM,COUNTRY,BLZ,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belize,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6277051,SCSUD_PHARM,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tunisia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6321014,SCSUD_PHARM,COUNTRY,ECU,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ecuador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6322142,SCSUD_PHARM,COUNTRY,QAT,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Qatar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6328790,SCSUD_PHARM,COUNTRY,SLE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sierra Leone,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6348755,SCSUD_PHARM,COUNTRY,PER,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Peru,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6353184,SCSUD_PHARM,COUNTRY,ATG,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Antigua and Barbuda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6366971,SCSUD_PHARM,COUNTRY,CRI,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Costa Rica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6390842,SCSUD_PHARM,COUNTRY,MLT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malta,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6392521,SCSUD_PHARM,COUNTRY,SDN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6397166,SCSUD_PHARM,COUNTRY,DEU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Germany,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6403337,SCSUD_PHARM,COUNTRY,SSD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6441674,SCSUD_PHARM,COUNTRY,QAT,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Qatar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6480943,SCSUD_PHARM,COUNTRY,ISL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iceland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6492196,SCSUD_PHARM,COUNTRY,BLR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belarus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6493813,SCSUD_PHARM,COUNTRY,RWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Rwanda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6494697,SCSUD_PHARM,COUNTRY,MMR,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Myanmar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6525662,SCSUD_PHARM,COUNTRY,KGZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kyrgyzstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6526570,SCSUD_PHARM,COUNTRY,SSD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6562617,SCSUD_PHARM,COUNTRY,NPL,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nepal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6564201,SCSUD_PHARM,COUNTRY,GBR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6588576,SCSUD_PHARM,COUNTRY,HRV,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Croatia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6602005,SCSUD_PHARM,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tunisia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6608002,SCSUD_PHARM,COUNTRY,AFG,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Afghanistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6626333,SCSUD_PHARM,COUNTRY,POL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Poland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6633137,SCSUD_PHARM,COUNTRY,EST,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Estonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6644441,SCSUD_PHARM,COUNTRY,KEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kenya,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6696792,SCSUD_PHARM,COUNTRY,PAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Panama,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6709956,SCSUD_PHARM,COUNTRY,UKR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ukraine,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6727649,SCSUD_PHARM,COUNTRY,SLE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sierra Leone,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6732856,SCSUD_PHARM,COUNTRY,LCA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Lucia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6733634,SCSUD_PHARM,COUNTRY,BLR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belarus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6740648,SCSUD_PHARM,COUNTRY,MLI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mali,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6772368,SCSUD_PHARM,COUNTRY,GTM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guatemala,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6778873,SCSUD_PHARM,COUNTRY,BFA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burkina Faso,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6792247,SCSUD_PHARM,COUNTRY,GBR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6792306,SCSUD_PHARM,COUNTRY,UKR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ukraine,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6798987,SCSUD_PHARM,COUNTRY,SUR,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Suriname,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6810949,SCSUD_PHARM,COUNTRY,NGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nigeria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6848531,SCSUD_PHARM,COUNTRY,VNM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Viet Nam,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6855815,SCSUD_PHARM,COUNTRY,IND,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,India,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6885251,SCSUD_PHARM,COUNTRY,AND,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Andorra,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6898360,SCSUD_PHARM,COUNTRY,KNA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Kitts and Nevis,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6937412,SCSUD_PHARM,COUNTRY,MLT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malta,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6944339,SCSUD_PHARM,COUNTRY,CHE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Switzerland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6948546,SCSUD_PHARM,COUNTRY,GBR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
6999590,SCSUD_PHARM,COUNTRY,BOL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bolivia (Plurinational State of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7006338,SCSUD_PHARM,COUNTRY,BEL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belgium,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7030534,SCSUD_PHARM,COUNTRY,GRD,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Grenada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7043051,SCSUD_PHARM,COUNTRY,DOM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominican Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7050267,SCSUD_PHARM,COUNTRY,TUR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,TÃ¼rkiye,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7051722,SCSUD_PHARM,COUNTRY,LVA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Latvia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7058130,SCSUD_PHARM,COUNTRY,QAT,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Qatar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7076453,SCSUD_PHARM,COUNTRY,TUN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tunisia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7113532,SCSUD_PHARM,COUNTRY,LBR,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Liberia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7120269,SCSUD_PHARM,COUNTRY,QAT,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Qatar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7127709,SCSUD_PHARM,COUNTRY,BFA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burkina Faso,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7152802,SCSUD_PHARM,COUNTRY,KAZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kazakhstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7153066,SCSUD_PHARM,COUNTRY,FSM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Micronesia (Federated States of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7175882,SCSUD_PHARM,COUNTRY,HND,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Honduras,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7176386,SCSUD_PHARM,COUNTRY,KOR,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Korea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7182606,SCSUD_PHARM,COUNTRY,BEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Benin,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7203840,SCSUD_PHARM,COUNTRY,TKM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Turkmenistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7213824,SCSUD_PHARM,COUNTRY,VUT,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Vanuatu,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7229324,SCSUD_PHARM,COUNTRY,AFG,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Afghanistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7260933,SCSUD_PHARM,COUNTRY,ESP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Spain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7271103,SCSUD_PHARM,COUNTRY,FIN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Finland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7272248,SCSUD_PHARM,COUNTRY,LTU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Lithuania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7272820,SCSUD_PHARM,COUNTRY,CPV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cabo Verde,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7290034,SCSUD_PHARM,COUNTRY,DNK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Denmark,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7291722,SCSUD_PHARM,COUNTRY,BGD,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bangladesh,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7323504,SCSUD_PHARM,COUNTRY,FSM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Micronesia (Federated States of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7349377,SCSUD_PHARM,COUNTRY,SOM,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Somalia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7349527,SCSUD_PHARM,COUNTRY,EST,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Estonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7360413,SCSUD_PHARM,COUNTRY,CPV,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cabo Verde,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7361239,SCSUD_PHARM,COUNTRY,VCT,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Vincent and the Grenadines,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7368901,SCSUD_PHARM,COUNTRY,JAM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jamaica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7385748,SCSUD_PHARM,COUNTRY,AND,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Andorra,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7394058,SCSUD_PHARM,COUNTRY,NGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nigeria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7397866,SCSUD_PHARM,COUNTRY,NLD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Netherlands (Kingdom of the),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7412098,SCSUD_PHARM,COUNTRY,KGZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kyrgyzstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7429930,SCSUD_PHARM,COUNTRY,BEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Benin,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7431034,SCSUD_PHARM,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saudi Arabia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7448529,SCSUD_PHARM,COUNTRY,NZL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,New Zealand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7448764,SCSUD_PHARM,COUNTRY,KAZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kazakhstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7449941,SCSUD_PHARM,COUNTRY,SGP,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Singapore,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7457264,SCSUD_PHARM,COUNTRY,AFG,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Afghanistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7468511,SCSUD_PHARM,COUNTRY,SDN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7493425,SCSUD_PHARM,COUNTRY,VUT,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Vanuatu,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7500678,SCSUD_PHARM,COUNTRY,KOR,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Korea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7526261,SCSUD_PHARM,COUNTRY,BTN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bhutan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7533266,SCSUD_PHARM,COUNTRY,KNA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Kitts and Nevis,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7551529,SCSUD_PHARM,COUNTRY,SYC,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Seychelles,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7552268,SCSUD_PHARM,COUNTRY,NLD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Netherlands (Kingdom of the),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7564889,SCSUD_PHARM,COUNTRY,MKD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,North Macedonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7588387,SCSUD_PHARM,COUNTRY,RWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Rwanda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7603400,SCSUD_PHARM,COUNTRY,KNA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Kitts and Nevis,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7607522,SCSUD_PHARM,COUNTRY,JAM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jamaica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7620673,SCSUD_PHARM,COUNTRY,SOM,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Somalia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7664334,SCSUD_PHARM,COUNTRY,BTN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bhutan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7666015,SCSUD_PHARM,COUNTRY,ZMB,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zambia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7678788,SCSUD_PHARM,COUNTRY,TUR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,TÃ¼rkiye,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7690492,SCSUD_PHARM,COUNTRY,KNA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Kitts and Nevis,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7716207,SCSUD_PHARM,COUNTRY,SYR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Syrian Arab Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7721788,SCSUD_PHARM,COUNTRY,COK,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cook Islands,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7728906,SCSUD_PHARM,COUNTRY,PRY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Paraguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7729532,SCSUD_PHARM,COUNTRY,TCD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chad,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7741408,SCSUD_PHARM,COUNTRY,MEX,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mexico,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7742814,SCSUD_PHARM,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bahrain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7746476,SCSUD_PHARM,COUNTRY,PER,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Peru,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7753207,SCSUD_PHARM,COUNTRY,SYR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Syrian Arab Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7766120,SCSUD_PHARM,COUNTRY,GHA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ghana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7773695,SCSUD_PHARM,COUNTRY,SDN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7785395,SCSUD_PHARM,COUNTRY,FSM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Micronesia (Federated States of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7798239,SCSUD_PHARM,COUNTRY,LBR,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Liberia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7830716,SCSUD_PHARM,COUNTRY,MOZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mozambique,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7850873,SCSUD_PHARM,COUNTRY,COD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Democratic Republic of the Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7854438,SCSUD_PHARM,COUNTRY,MYS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malaysia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7861561,SCSUD_PHARM,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bahrain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7875904,SCSUD_PHARM,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saudi Arabia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7901629,SCSUD_PHARM,COUNTRY,PRY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Paraguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7958943,SCSUD_PHARM,COUNTRY,VUT,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Vanuatu,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
7990308,SCSUD_PHARM,COUNTRY,EGY,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Egypt,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8039508,SCSUD_PHARM,COUNTRY,BOL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bolivia (Plurinational State of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8085218,SCSUD_PHARM,COUNTRY,GUY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Guyana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8097467,SCSUD_PHARM,COUNTRY,IND,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,India,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8115600,SCSUD_PHARM,COUNTRY,SWE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sweden,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8129123,SCSUD_PHARM,COUNTRY,GHA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ghana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8134960,SCSUD_PHARM,COUNTRY,GBR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Kingdom of Great Britain and Northern Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8154266,SCSUD_PHARM,COUNTRY,PAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Panama,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8155329,SCSUD_PHARM,COUNTRY,BWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Botswana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8165492,SCSUD_PHARM,COUNTRY,MLI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mali,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8173953,SCSUD_PHARM,COUNTRY,AUS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Australia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8178420,SCSUD_PHARM,COUNTRY,DNK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Denmark,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8180061,SCSUD_PHARM,COUNTRY,UGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uganda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8197671,SCSUD_PHARM,COUNTRY,FRA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,France,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8248110,SCSUD_PHARM,COUNTRY,CAN,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Canada,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8261424,SCSUD_PHARM,COUNTRY,IRL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8273766,SCSUD_PHARM,COUNTRY,TKM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Turkmenistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8307405,SCSUD_PHARM,COUNTRY,MKD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,North Macedonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8324988,SCSUD_PHARM,COUNTRY,ARM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Armenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8339277,SCSUD_PHARM,COUNTRY,ATG,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Antigua and Barbuda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8355926,SCSUD_PHARM,COUNTRY,SWZ,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Eswatini,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8362383,SCSUD_PHARM,COUNTRY,HUN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Hungary,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8374701,SCSUD_PHARM,COUNTRY,JPN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Japan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8383344,SCSUD_PHARM,COUNTRY,ZWE,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zimbabwe,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8393641,SCSUD_PHARM,COUNTRY,DNK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Denmark,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8396324,SCSUD_PHARM,COUNTRY,MLT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malta,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8433015,SCSUD_PHARM,COUNTRY,SEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Senegal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8459470,SCSUD_PHARM,COUNTRY,TON,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tonga,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8470149,SCSUD_PHARM,COUNTRY,IRL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8483104,SCSUD_PHARM,COUNTRY,KHM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cambodia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8515901,SCSUD_PHARM,COUNTRY,TCD,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Chad,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8560876,SCSUD_PHARM,COUNTRY,AGO,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Angola,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8565329,SCSUD_PHARM,COUNTRY,SWE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sweden,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8571936,SCSUD_PHARM,COUNTRY,SGP,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Singapore,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8572152,SCSUD_PHARM,COUNTRY,DEU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Germany,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8573253,SCSUD_PHARM,COUNTRY,CHE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Switzerland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8579922,SCSUD_PHARM,COUNTRY,IDN,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Indonesia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8609087,SCSUD_PHARM,COUNTRY,ECU,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ecuador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8621452,SCSUD_PHARM,COUNTRY,ESP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Spain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8621654,SCSUD_PHARM,COUNTRY,IRN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iran (Islamic Republic of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8624223,SCSUD_PHARM,COUNTRY,SYC,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Seychelles,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8627786,SCSUD_PHARM,COUNTRY,LCA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saint Lucia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8653791,SCSUD_PHARM,COUNTRY,BHR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Bahrain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8661023,SCSUD_PHARM,COUNTRY,BLR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belarus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8698407,SCSUD_PHARM,COUNTRY,TJK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tajikistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8743336,SCSUD_PHARM,COUNTRY,AFG,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Afghanistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8748367,SCSUD_PHARM,COUNTRY,DEU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Germany,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8754820,SCSUD_PHARM,COUNTRY,KEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kenya,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8768646,SCSUD_PHARM,COUNTRY,MCO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Monaco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8773414,SCSUD_PHARM,COUNTRY,BDI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burundi,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8775930,SCSUD_PHARM,COUNTRY,MCO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Monaco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8786831,SCSUD_PHARM,COUNTRY,TZA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Republic of Tanzania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8799953,SCSUD_PHARM,COUNTRY,SAU,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Saudi Arabia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8807056,SCSUD_PHARM,COUNTRY,EGY,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Egypt,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8812467,SCSUD_PHARM,COUNTRY,HUN,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Hungary,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8824106,SCSUD_PHARM,COUNTRY,UGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uganda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8824108,SCSUD_PHARM,COUNTRY,NOR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Norway,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8833163,SCSUD_PHARM,COUNTRY,OMN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Oman,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8839114,SCSUD_PHARM,COUNTRY,NZL,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,New Zealand,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8845868,SCSUD_PHARM,COUNTRY,SYC,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Seychelles,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8850305,SCSUD_PHARM,COUNTRY,MNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mongolia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8850641,SCSUD_PHARM,COUNTRY,CUB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cuba,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8856651,SCSUD_PHARM,COUNTRY,COK,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cook Islands,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8869118,SCSUD_PHARM,COUNTRY,SYC,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Seychelles,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8870707,SCSUD_PHARM,COUNTRY,ROU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Romania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8876431,SCSUD_PHARM,COUNTRY,SWE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sweden,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8881331,SCSUD_PHARM,COUNTRY,MKD,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,North Macedonia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8881831,SCSUD_PHARM,COUNTRY,MLT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malta,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8882353,SCSUD_PHARM,COUNTRY,MLI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mali,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8894589,SCSUD_PHARM,COUNTRY,JPN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Japan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8946019,SCSUD_PHARM,COUNTRY,AUT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Austria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8947047,SCSUD_PHARM,COUNTRY,MCO,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Monaco,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8957842,SCSUD_PHARM,COUNTRY,ARM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Armenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8969975,SCSUD_PHARM,COUNTRY,SDN,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sudan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
8970146,SCSUD_PHARM,COUNTRY,QAT,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Qatar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9003336,SCSUD_PHARM,COUNTRY,COL,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Colombia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9016331,SCSUD_PHARM,COUNTRY,LTU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Lithuania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9020947,SCSUD_PHARM,COUNTRY,EGY,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Egypt,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9022632,SCSUD_PHARM,COUNTRY,BRB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Barbados,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9027456,SCSUD_PHARM,COUNTRY,IND,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,India,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9053436,SCSUD_PHARM,COUNTRY,ESP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Spain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9060164,SCSUD_PHARM,COUNTRY,LKA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sri Lanka,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9066930,SCSUD_PHARM,COUNTRY,ZAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Africa,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9086156,SCSUD_PHARM,COUNTRY,CRI,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Costa Rica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9122133,SCSUD_PHARM,COUNTRY,ISR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Israel,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9122724,SCSUD_PHARM,COUNTRY,TON,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tonga,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9130825,SCSUD_PHARM,COUNTRY,KHM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cambodia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9156066,SCSUD_PHARM,COUNTRY,VUT,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Vanuatu,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9162318,SCSUD_PHARM,COUNTRY,QAT,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Qatar,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9169074,SCSUD_PHARM,COUNTRY,DNK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Denmark,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9182137,SCSUD_PHARM,COUNTRY,NGA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nigeria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9200029,SCSUD_PHARM,COUNTRY,MDA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Moldova,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9212145,SCSUD_PHARM,COUNTRY,BLZ,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belize,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9250273,SCSUD_PHARM,COUNTRY,KOR,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Republic of Korea,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9320245,SCSUD_PHARM,COUNTRY,COG,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9339138,SCSUD_PHARM,COUNTRY,JAM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jamaica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9346343,SCSUD_PHARM,COUNTRY,SRB,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Serbia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9358461,SCSUD_PHARM,COUNTRY,RWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Rwanda,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9370003,SCSUD_PHARM,COUNTRY,LBR,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Liberia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9371285,SCSUD_PHARM,COUNTRY,CHE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Switzerland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9391531,SCSUD_PHARM,COUNTRY,MYS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malaysia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9403859,SCSUD_PHARM,COUNTRY,LUX,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Luxembourg,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9433062,SCSUD_PHARM,COUNTRY,NOR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Norway,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9471679,SCSUD_PHARM,COUNTRY,PER,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Peru,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9491331,SCSUD_PHARM,COUNTRY,IRL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9498046,SCSUD_PHARM,COUNTRY,POL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Poland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9503323,SCSUD_PHARM,COUNTRY,MNG,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Mongolia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9517088,SCSUD_PHARM,COUNTRY,GRC,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Greece,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9521739,SCSUD_PHARM,COUNTRY,PER,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Peru,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9541448,SCSUD_PHARM,COUNTRY,IRL,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ireland,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9559037,SCSUD_PHARM,COUNTRY,DMA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9573650,SCSUD_PHARM,COUNTRY,AUT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Austria,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9584573,SCSUD_PHARM,COUNTRY,LKA,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sri Lanka,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9635145,SCSUD_PHARM,COUNTRY,URY,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Uruguay,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9635369,SCSUD_PHARM,COUNTRY,ESP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Spain,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9636681,SCSUD_PHARM,COUNTRY,CYP,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cyprus,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9637205,SCSUD_PHARM,COUNTRY,PAK,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Pakistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9642600,SCSUD_PHARM,COUNTRY,AGO,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Angola,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9662078,SCSUD_PHARM,COUNTRY,BEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Benin,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9686261,SCSUD_PHARM,COUNTRY,BDI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burundi,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9731742,SCSUD_PHARM,COUNTRY,MYS,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malaysia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9732044,SCSUD_PHARM,COUNTRY,LTU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Lithuania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9736359,SCSUD_PHARM,COUNTRY,SMR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,San Marino,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9763846,SCSUD_PHARM,COUNTRY,ARM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Armenia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9763957,SCSUD_PHARM,COUNTRY,ETH,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ethiopia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9786493,SCSUD_PHARM,COUNTRY,BRB,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Barbados,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9788631,SCSUD_PHARM,COUNTRY,BDI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burundi,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9793030,SCSUD_PHARM,COUNTRY,ISR,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Israel,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9794161,SCSUD_PHARM,COUNTRY,CHN,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,China,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9799905,SCSUD_PHARM,COUNTRY,PRT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Portugal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9812194,SCSUD_PHARM,COUNTRY,LTU,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Lithuania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9812229,SCSUD_PHARM,COUNTRY,SVK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovakia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9824918,SCSUD_PHARM,COUNTRY,DMA,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominica,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9832381,SCSUD_PHARM,COUNTRY,KGZ,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Kyrgyzstan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9850827,SCSUD_PHARM,COUNTRY,COK,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cook Islands,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9863294,SCSUD_PHARM,COUNTRY,TJK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Tajikistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9863622,SCSUD_PHARM,COUNTRY,BEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Benin,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9869730,SCSUD_PHARM,COUNTRY,ZMB,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Zambia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9876670,SCSUD_PHARM,COUNTRY,TKM,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Turkmenistan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9882519,SCSUD_PHARM,COUNTRY,BLZ,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Belize,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9888272,SCSUD_PHARM,COUNTRY,MLT,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Malta,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9896819,SCSUD_PHARM,COUNTRY,SEN,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Senegal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9903172,SCSUD_PHARM,COUNTRY,SWE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sweden,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9915233,SCSUD_PHARM,COUNTRY,BDI,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Burundi,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9928750,SCSUD_PHARM,COUNTRY,COG,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_noncompwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Congo,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9940195,SCSUD_PHARM,COUNTRY,CAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Central African Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9946167,SCSUD_PHARM,COUNTRY,SVK,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Slovakia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9963911,SCSUD_PHARM,COUNTRY,ETH,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Ethiopia,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9978253,SCSUD_PHARM,COUNTRY,BWA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Botswana,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
9989756,SCSUD_PHARM,COUNTRY,SWE,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Sweden,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10002776,SCSUD_PHARM,COUNTRY,FSM,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_emergency_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Micronesia (Federated States of),"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10021611,SCSUD_PHARM,COUNTRY,ZAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_otherthan_oamt,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Africa,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10033675,SCSUD_PHARM,COUNTRY,IRQ,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0.66,0.66,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Iraq,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10073251,SCSUD_PHARM,COUNTRY,TZA,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,United Republic of Tanzania,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10105134,SCSUD_PHARM,COUNTRY,JOR,YEAR,EMR,Eastern Mediterranean,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_compwithdrwl_syndrome,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Jordan,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10111531,SCSUD_PHARM,COUNTRY,DOM,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_21_geo_coverage_pharmacological,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,1.33,1.33,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Dominican Republic,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10118241,SCSUD_PHARM,COUNTRY,COK,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_19_pharmacological_treatment_exist,2023,SUBSTANCETYPE,SUBSTANCETYPE_DRUGS,NA,NA,NA,NA,2,2,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Cook Islands,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10123230,SCSUD_PHARM,COUNTRY,ITA,YEAR,EUR,Europe,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Italy,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10134899,SCSUD_PHARM,COUNTRY,SLV,YEAR,AMR,Americas,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_oamt_opoid_dependence,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,El Salvador,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10143099,SCSUD_PHARM,COUNTRY,ZAF,YEAR,AFR,Africa,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,South Africa,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10162692,SCSUD_PHARM,COUNTRY,SGP,YEAR,WPR,Western Pacific,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_prog_for_drug_od_prevention,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,0,0,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Singapore,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
10167794,SCSUD_PHARM,COUNTRY,NPL,YEAR,SEAR,South-East Asia,SCSUDSURVEYQUESTIONS,SCSUDSURVEYQUESTIONS_SCSUD40_20_pharmtreatment_of_comorbid_conditions,2023,SUBSTANCETYPE,SUBSTANCETYPE_ALCOHOL,NA,NA,NA,NA,1,1,NA,NA,NA,2024-09-03T10:09:22.71+02:00,2023,2023-01-01T00:00:00+01:00,2023-12-31T00:00:00+01:00,Nepal,"Substance use disorders service coverage, pharmacological treatment services",EN,Service coverage for substance use disorders survey
